PART II. OTHER INFORMATION

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4. CONTROLS AND PROCEDURES

ITEM 1. LEGAL PROCEEDINGS

ITEM 1A. RISK FACTORS

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 6. EXHIBITS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-11239

HCA Healthcare, Inc.

(615) 344-9551

Not Applicable

Securities registered pursuant to Section 12(b) of the Act:

HCA HEALTHCARE, INC.

Form 10-Q

March 31, 2022

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATED INCOME STATEMENTS

FOR THE QUARTERS ENDED MARCH 31, 2022 AND 2021

Unaudited

The accompanying notes are an integral part of the condensed consolidated financial statements.

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS

FOR THE QUARTERS ENDED MARCH 31, 2022 AND 2021

Unaudited

The accompanying notes are an integral part of the condensed consolidated financial statements.

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Unaudited

The accompanying notes are an integral part of the condensed consolidated financial statements.

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE QUARTERS ENDED MARCH 31, 2022 AND 2021

Unaudited

The accompanying notes are an integral part of the condensed consolidated financial statements.

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE QUARTERS ENDED MARCH 31, 2022 AND 2021

Unaudited

The accompanying notes are an integral part of the condensed consolidated financial statements.

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

COVID-19

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 1 — BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (continued)

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued)

NOTE 3 — INCOME TAXES

NOTE 4 — EARNINGS PER SHARE

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

6.0

9.0

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 8 — LONG-TERM DEBT

3 1/8

3 3/8

3 5/8

4 3/8

4 5/8

NOTE 9 — CONTINGENCIES

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES (continued)

NOTE 10 — SHARE REPURCHASE TRANSACTIONS AND OTHER COMPREHENSIVE LOSS

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

HCA HEALTHCARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

COVID-19

First Quarter 2022 Operations Summary

Results of Operations

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Liquidity and Capital Resources

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

Tax Examinations

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Operating Data

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Evaluation of Disclosure Controls and Procedures

Changes in Internal Control Over Financial Reporting

SIGNATURES

Reporting Entity

Basis of Presentation

Revenues

Revenues (continued)

Reclassifications

Investment Securities

Derivative Financial Instrument

Revenue/Volume Trends

Revenue/Volume Trends (continued)

Revenue/Volume Trends (continued)

Key Performance Indicators

Operating Results Summary

Quarters Ended March 31, 2022 and 2021

Quarters Ended March 31, 2022 and 2021 (continued)

Summarized Financial Information

Summarized Financial Information (continued)

Summarized Financial Information (continued)

Market Risk

Market Risk (continued)

(Mark One)

(Exact name of registrant as specified in its charter)

Delaware	27-3865930
(State or other jurisdiction of<br><br>incorporation or organization)	(I.R.S. Employer<br><br>Identification No.)
One Park Plaza<br><br>Nashville, Tennessee	37203
(Address of principal executive offices)	(Zip Code)

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Voting common stock, $.01 par value	HCA	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

Class of Common Stock	Outstanding at April 29, 2022
Voting common stock, $.01 par value	295,484,400 shares

		Page of<br>Form 10-Q
Part I.	Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Income Statements — for the quarters ended March 31, 2022 and 2021	3
	Condensed Consolidated Comprehensive Income Statements — for the quarters ended March 31, 2022 and 2021	4
	Condensed Consolidated Balance Sheets — March 31, 2022 and December 31, 2021	5
	Condensed Consolidated Statements of Stockholders’ Equity — for the quarters ended March 31, 2022 and 2021	6
	Condensed Consolidated Statements of Cash Flows — for the quarters ended March 31, 2022 and 2021	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
Item 4.	Controls and Procedures	30
Part II.	Other Information
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
Item 6.	Exhibits	32
Signatures		34

(Dollars in millions, except per share amounts)

	2022			2021
Revenues	$	14,945		$	13,977
Salaries and benefits		6,939			6,301
Supplies		2,321			2,224
Other operating expenses		2,752			2,421
Equity in earnings of affiliates		(11	)		(21	)
Depreciation and amortization		732			697
Interest expense		408			384
Gains on sales of facilities		(10	)		(2	)
		13,131			12,004
Income before income taxes		1,814			1,973
Provision for income taxes		349			393
Net income		1,465			1,580
Net income attributable to noncontrolling interests		192			157
Net income attributable to HCA Healthcare, Inc.	$	1,273		$	1,423
Per share data:
Basic earnings	$	4.21		$	4.21
Diluted earnings	$	4.14		$	4.14
Shares used in earnings per share calculations (in millions):
Basic		302.446			338.123
Diluted		307.374			343.321

(Dollars in millions)

	2022			2021
Net income	$	1,465		$	1,580
Other comprehensive income (loss) before taxes:
Foreign currency translation		(34	)		8
Unrealized losses on available-for-sale securities		(26	)		(11	)
Defined benefit plans		—			—
Pension costs included in salaries and benefits		2			7
		2			7
Change in fair value of derivative financial instruments		4			1
Interest costs included in interest expense		2			9
		6			10
Other comprehensive income (loss) before taxes		(52	)		14
Income taxes (benefits) related to other comprehensive income ("OCI") items		(9	)		3
Other comprehensive income (loss)		(43	)		11
Comprehensive income		1,422			1,591
Comprehensive income attributable to noncontrolling interests		192			157
Comprehensive income attributable to HCA Healthcare, Inc.	$	1,230		$	1,434

(Dollars in millions)

			December 31,<br>2021
ASSETS
Current assets:
Cash and cash equivalents	2,371		$	1,451
Accounts receivable	8,520			8,095
Inventories	2,003			1,986
Other	2,112			2,010
	15,006			13,542
Property and equipment, at cost	52,042			51,350
Accumulated depreciation	(27,814	)		(27,287	)
	24,228			24,063
Investments of insurance subsidiaries	408			438
Investments in and advances to affiliates	441			448
Goodwill and other intangible assets	9,525			9,540
Right-of-use operating lease assets	2,138			2,113
Other	462			598
	52,208		$	50,742
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	4,010		$	4,111
Accrued salaries	1,865			1,912
Other accrued expenses	3,157			3,322
Long-term debt due within one year	1,486			237
	10,518			9,582
Long-term debt, less debt issuance costs and discounts of 323 and 248	36,210			34,342
Professional liability risks	1,508			1,514
Right-of-use operating lease obligations	1,790			1,755
Income taxes and other liabilities	1,768			2,060
Stockholders’ equity:
Common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021	3			3
Accumulated other comprehensive loss	(447	)		(404	)
Retained deficit	(1,589	)		(532	)
Stockholders’ deficit attributable to HCA Healthcare, Inc.	(2,033	)		(933	)
Noncontrolling interests	2,447			2,422
	414			1,489
	52,208		$	50,742

All values are in US Dollars.

(Dollars in millions)


					Capital			Accumulated						Equity
					in Excess			Other			Retained			Attributable to
			Par		of Par			Comprehensive			Earnings			Noncontrolling
			Value		Value			Loss			(Deficit)			Interests			Total
Balances, December 31, 2020	339.426		$	3	$	294		$	(502	)	$	777		$	2,320		$	2,892
Comprehensive income									11			1,423			157			1,591
Repurchase of common stock	(8.477	)				(225	)					(1,302	)					(1,527	)
Share-based benefit plans	2.765					(75	)											(75	)
Cash dividends declared (0.48 per share)												(163	)					(163	)
Distributions															(234	)		(234	)
Other						6									(8	)		(2	)
Balances, March 31, 2021	333.714			3		—			(491	)		735			2,235			2,482
Comprehensive income									16			1,450			214			1,680
Repurchase of common stock	(11.261	)				(142	)					(2,145	)					(2,287	)
Share-based benefit plans	0.372					140												140
Cash dividends declared (0.48 per share)												(161	)					(161	)
Distributions															(123	)		(123	)
Other						2									57			59
Balances, June 30, 2021	322.825			3		—			(475	)		(121	)		2,383			1,790
Comprehensive income									(17	)		2,269			203			2,455
Repurchase of common stock	(9.605	)				(130	)					(2,199	)					(2,329	)
Share-based benefit plans	0.282					127												127
Cash dividends declared (0.48 per share)												(155	)					(155	)
Distributions															(144	)		(144	)
Other						3									78			81
Balances, September 30, 2021	313.502			3		—			(492	)		(206	)		2,520			1,825
Comprehensive income									88			1,814			191			2,093
Repurchase of common stock	(8.469	)				(81	)					(1,991	)					(2,072	)
Share-based benefit plans	0.444					88												88
Cash dividends declared (0.48 per share)												(149	)					(149	)
Distributions															(248	)		(248	)
Other						(7	)								(41	)		(48	)
Balances, December 31, 2021	305.477			3		—			(404	)		(532	)		2,422			1,489
Comprehensive income									(43	)		1,273			192			1,422
Repurchase of common stock	(8.375	)										(2,101	)					(2,101	)
Share-based benefit plans	1.879											(57	)					(57	)
Cash dividends declared (0.56 per share)												(171	)					(171	)
Distributions															(171	)		(171	)
Other												(1	)		4			3
Balances, March 31, 2022	298.981		$	3	$	—		$	(447	)	$	(1,589	)	$	2,447		$	414

All values are in US Dollars.

(Dollars in millions)

	2022			2021
Cash flows from operating activities:
Net income	$	1,465		$	1,580
Adjustments to reconcile net income to net cash provided by operating activities:
Decrease in cash from operating assets and liabilities:
Accounts receivable		(427	)		(371	)
Inventories and other assets		(121	)		(85	)
Accounts payable and accrued expenses		(771	)		(371	)
Depreciation and amortization		732			697
Income taxes		346			406
Gains on sales of facilities		(10	)		(2	)
Amortization of debt issuance costs and discounts		7			8
Share-based compensation		86			97
Other		38			29
Net cash provided by operating activities		1,345			1,988
Cash flows from investing activities:
Purchase of property and equipment		(861	)		(654	)
Acquisition of hospitals and health care entities		(2	)		(22	)
Sales of hospitals and health care entities		14			20
Change in investments		10			(2	)
Other		(6	)		9
Net cash used in investing activities		(845	)		(649	)
Cash flows from financing activities:
Issuance of long-term debt		5,966			—
Net change in revolving credit facilities		(2,780	)		80
Repayment of long-term debt		(66	)		(47	)
Distributions to noncontrolling interests		(171	)		(234	)
Payment of debt issuance costs		(49	)		—
Payment of dividends		(177	)		(169	)
Repurchase of common stock		(2,101	)		(1,527	)
Other		(197	)		(207	)
Net cash provided by (used in) financing activities		425			(2,104	)
Effect of exchange rate changes on cash and cash equivalents		(5	)		2
Change in cash and cash equivalents		920			(763	)
Cash and cash equivalents at beginning of period		1,451			1,793
Cash and cash equivalents at end of period	$	2,371		$	1,030
Interest payments	$	408		$	375
Income tax payments (refunds), net	$	3		$	(13	)

HCA Healthcare, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Healthcare, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At March 31, 2022, these affiliates owned and operated 182 hospitals, 124 freestanding surgery centers, 21 freestanding endoscopy centers and provided extensive outpatient and ancillary services. HCA Healthcare, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Healthcare, Inc. and its affiliates. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively. Operating results for the quarter are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2021.

On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. We believe the extent of COVID-19’s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast. Because of these uncertainties, we cannot estimate how long or to what extent COVID-19 will impact our operations.

Our revenues generally relate to contracts with patients in which our performance obligations are to provide health care services to the patients. Revenues are recorded during the period our obligations to provide health care services are satisfied. Our performance obligations for inpatient services are generally satisfied over periods that average approximately five days, and revenues are recognized based on charges incurred in relation to total expected charges. Our performance obligations for outpatient services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify payments at amounts less than our standard charges. Medicare generally pays for inpatient and outpatient services at prospectively determined rates based on clinical, diagnostic and other factors. Services provided to patients having Medicaid coverage are generally paid at prospectively determined rates per discharge, per identified service or per covered member. Agreements with commercial insurance carriers, managed care and preferred provider organizations generally provide for payments based upon predetermined rates per diagnosis, per diem rates or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.

Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payers. Estimates of contractual adjustments under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record these revenues at the estimated amounts we expect to collect. Patients treated at our hospitals for non-elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Our revenues by primary third-party payer classification and other (including uninsured patients) for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions):

	2022				2021
Medicare	$	2,726	18.2	%	$	2,559	18.3	%
Managed Medicare		2,324	15.6			2,053	14.7
Medicaid		579	3.9			527	3.8
Managed Medicaid		1,110	7.4			725	5.2
Managed care and insurers		7,152	47.9			6,885	49.1
International (managed care and insurers)		356	2.4			333	2.4
Other		698	4.6			895	6.5
Revenues	$	14,945	100.0	%	$	13,977	100.0	%

Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services ("CMS") approval of a Texas directed payment program for the current program year that began September 1, 2021.

To quantify the total impact of the trends related to uninsured patient accounts, we believe it is beneficial to view total uncompensated care, which is comprised of charity care, uninsured discounts and implicit price concessions. A summary of the estimated cost of total uncompensated care for the quarters ended March 31, 2022 and 2021 follows (dollars in millions):

	2022			2021
Patient care costs (salaries and benefits, supplies, other operating expense and depreciation<br> and amortization)	$	12,744		$	11,643
Cost-to-charges ratio (patient care costs as percentage of gross patient charges)		11.3	%		11.4	%
Total uncompensated care	$	7,005		$	6,821
Multiply by the cost-to-charges ratio		11.3	%		11.4	%
Estimated cost of total uncompensated care	$	792		$	778

The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.

Certain prior year amounts have been reclassified to conform to the current year presentation.

During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values.

During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.

Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.

Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.

At March 31, 2022, the Internal Revenue Service was conducting examinations of the Company’s 2016, 2017 and 2018 federal income tax returns and the 2019 return for one affiliated partnership. We are also subject to examination by state and foreign taxing authorities. Depending on the resolution of any federal, state and foreign tax disputes, the completion of examinations by federal, state or foreign taxing authorities, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible that our liability for unrecognized tax benefits may significantly increase or decrease within the next 12 months. However, we are currently unable to estimate the range of any possible change.

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding equity awards, computed using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share for the quarters ended March 31, 2022 and 2021 (dollars and shares in millions, except per share amounts):

	2022		2021
Net income attributable to HCA Healthcare, Inc.	$	1,273	$	1,423
Weighted average common shares outstanding		302.446		338.123
Effect of dilutive incremental shares		4.928		5.198
Shares used for diluted earnings per share		307.374		343.321
Earnings per share:
Basic earnings	$	4.21	$	4.21
Diluted earnings	$	4.14	$	4.14

A summary of our insurance subsidiaries’ investments at March 31, 2022 and December 31, 2021 follows (dollars in millions):

	March 31, 2022
			Unrealized<br>Amounts
	Amortized<br>Cost		Gains		Losses			Fair<br>Value
Debt securities	$	411	$	4	$	(14	)	$	401
Money market funds and other		112		—		—			112
	$	523	$	4	$	(14	)		513
Amounts classified as current assets									(105	)
Investment carrying value								$	408
	December 31, 2021
---	---	---	---	---	---	---	---	---	---	---
			Unrealized<br>Amounts
	Amortized<br>Cost		Gains		Losses			Fair<br>Value
Debt securities	$	400	$	18	$	(2	)	$	416
Money market funds and other		125		—		—			125
	$	525	$	18	$	(2	)		541
Amounts classified as current assets									(103	)
Investment carrying value								$	438

At March 31, 2022 and December 31, 2021, the investments in debt securities of our insurance subsidiaries were classified as “available-for-sale.” Changes in unrealized gains and losses that are not credit-related are recorded as adjustments to other comprehensive income (loss).

Scheduled maturities of investments in debt securities at March 31, 2022 were as follows (dollars in millions):

	Amortized<br>Cost		Fair<br>Value
Due in one year or less	$	8	$	8
Due after one year through five years		139		140
Due after five years through ten years		173		166
Due after ten years		91		87
	$	411	$	401

The average expected maturity of the investments in debt securities at March 31, 2022 was

years, compared to the average scheduled maturity of

years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to their scheduled maturity date.

The following table sets forth our interest rate swap agreement, which has been designated as a cash flow hedge, at March 31, 2022 (dollars in millions):

	Notional<br>Amount		Maturity Date	Fair<br>Value
Pay-fixed interest rate swap	$	500	December 2022	$	(2	)

The following table presents the effect of our interest rate swap on our results of operations for the quarter ended March 31, 2022 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain<br>Recognized in OCI on<br>Derivatives, Net of Tax	Location of Loss<br>Reclassified from<br>Accumulated OCI<br>into Operations	Amount of Loss<br>Reclassified from<br>Accumulated OCI<br>into Operations
Interest rate swap	$3	Interest expense	$2

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”), emphasizes fair value is a market-based measurement, and fair value measurements should be determined based on the assumptions market participants would use in pricing assets or liabilities. ASC 820 utilizes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment.

The investments of our insurance subsidiaries are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

We have entered into an interest rate swap agreement to manage our exposure to fluctuations in interest rates. The valuation of this instrument is determined using widely accepted valuation techniques, including a discounted expected cash flow analysis.

The following tables summarize our assets and liabilities measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	March 31, 2022
				Fair Value Measurements Using
	Fair Value			Quoted Prices in<br>Active Markets for<br>Identical Assets<br>and Liabilities<br>(Level 1)			Significant Other<br>Observable Inputs<br>(Level 2)		Significant<br>Unobservable Inputs<br>(Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities	$	401		$	—		$	401	$	—
Money market funds and other		112			112			—		—
Investments of insurance subsidiaries		513			112			401		—
Less amounts classified as current assets		(105	)		(105	)		—		—
	$	408		$	7		$	401	$	—
Liabilities:
Interest rate swap (Other accrued expenses)	$	2		$	—		$	2	$	—
	December 31, 2021
---	---	---	---	---	---	---	---	---	---	---
				Fair Value Measurements Using
	Fair Value			Quoted Prices in<br>Active Markets for<br>Identical Assets<br>and Liabilities<br>(Level 1)			Significant Other<br>Observable Inputs<br>(Level 2)		Significant<br>Unobservable Inputs<br>(Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities	$	416		$	—		$	416	$	—
Money market funds and other		125			125			—		—
Investments of insurance subsidiaries		541			125			416		—
Less amounts classified as current assets		(103	)		(103	)		—		—
	$	438		$	22		$	416	$	—
Liabilities:
Interest rate swap (Other accrued expenses)	$	8		$	—		$	8	$	—

The estimated fair value of our long-term debt was $39.038 billion and $38.541 billion at March 31, 2022 and December 31, 2021, respectively, compared to carrying amounts, excluding debt issuance costs and discounts, aggregating $38.019 billion and $34.827 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

A summary of long-term debt at March 31, 2022 and December 31, 2021, including related interest rates at March 31, 2022 follows (dollars in millions):

	March 31,<br>2022			December 31,<br>2021
Senior secured asset-based revolving credit facility	$	—		$	2,780
Senior secured revolving credit facility		—			—
Senior secured term loan facilities (effective interest rate of 2.3%)		1,940			1,960
Senior secured notes (effective interest rate of 4.6%)		22,200			16,200
Other senior secured debt (effective interest rate of 4.0%)		927			935
Senior secured debt		25,067			21,875
Senior unsecured notes (effective interest rate of 5.5%)		12,952			12,952
Debt issuance costs and discounts		(323	)		(248	)
Total debt (average life of 10.2 years, rates averaging 4.8%)		37,696			34,579
Less amounts due within one year		1,486			237
	$	36,210		$	34,342

During March 2022, we issued $6.000 billion aggregate principal amount of senior secured notes comprised of (i) $1.000 billion aggregate principal amount of

% senior secured notes due 2027, (ii) $500 million aggregate principal amount of

% senior secured notes due 2029, (iii) $2.000 billion aggregate principal amount of

% senior secured notes due 2032, (iv) $500 million aggregate principal amount of

% senior secured notes due 2042 and (v) $2.000 billion aggregate principal amount of

% senior secured notes due 2052. During March 2022, we used a portion of the net proceeds to pay down our revolving credit facilities. During April 2022, we redeemed all $1.250 billion outstanding aggregate principal amount of our 4.75% senior secured notes due 2023 and provided a notice of our election to redeem all $1.250 billion outstanding aggregate principal amount of our 5.875% senior notes due 2023. We expect to record aggregate pretax losses on retirement of debt for these two redemptions of approximately $80 million during the second quarter of 2022.

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. We are also subject to claims by various taxing authorities for additional taxes and related interest and penalties. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations, financial position or liquidity.

Health care companies are routinely subject to investigations by various governmental agencies. Under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our results of operations, financial position or liquidity.

Texas operates a state Medicaid program pursuant to a waiver from CMS under Section 1115 of the Social Security Act (“Program”). The Program includes uncompensated-care pools; payments from these pools are intended to defray the uncompensated costs of services provided by our and other hospitals to Medicaid eligible or uninsured individuals. Separately, we and other hospitals provide charity care services in several communities in the state. In 2018, the Civil Division of the U.S. Department of Justice and the U.S. Attorney’s Office for the Southern District of Texas requested information about whether the Program, as operated in Harris County, complied with the laws and regulations applicable to provider related donations, and the Company cooperated with that request. On May 21, 2019, a qui tam lawsuit asserting violations of the FCA and the Texas Medicaid Fraud Prevention Act related to the Program, as operated in Harris County, was unsealed by the U.S. District Court for the Southern District of Texas. Both the federal and state governments declined to intervene in the qui tam lawsuit. The Company believes that our participation is and has been consistent with the requirements of the Program and is vigorously defending against the lawsuit being pursued by the relator. We cannot predict what effect, if any, the qui tam lawsuit could have on the Company.

During January 2022 and February 2021, our Board of Directors authorized share repurchase programs for up to $8 billion and $6 billion, respectively, of our outstanding common stock. During the quarter ended March 31, 2022, we repurchased 8.375 million shares of our common stock at an average price of $250.89 per share through market purchases pursuant to the February 2021 authorization (which was completed during the first quarter of 2022) and the January 2022 authorization. At March 31, 2022, we had $6.485 billion of repurchase authorization available under the January 2022 authorization.

The components of accumulated other comprehensive loss are as follows (dollars in millions):

			Foreign<br>Currency<br>Translation<br>Adjustments			Defined<br>Benefit<br>Plans			Change<br>in Fair<br>Value of<br>Derivative<br>Instruments			Total
Balances at December 31, 2021	12		$	(278	)	$	(132	)	$	(6	)	$	(404	)
Unrealized losses on available-for-sale securities, net of 6 income tax benefit	(20	)											(20	)
Foreign currency translation adjustments, net of 4 income tax benefit				(30	)								(30	)
Change in fair value of derivative instruments, net of 1 of income taxes										3			3
Expense reclassified into operations from other comprehensive income							2			2			4
Balances at March 31, 2022	(8	)	$	(308	)	$	(130	)	$	(1	)	$	(447	)

All values are in US Dollars.

We operate in one line of business, which is operating hospitals and related health care entities. We operate in two geographically organized groups: the National and American Groups. The National Group includes 96 hospitals located in Alaska, California, Florida, Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, North Carolina, South Carolina, Utah and Virginia, and the American Group includes 79 hospitals located in Colorado, Kansas, southern Kentucky, Louisiana, Missouri, Tennessee and Texas. We also operate seven hospitals in England, and these facilities are included in the Corporate and other group.

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, gains on sales of facilities, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions):

	2022			2021
Revenues:
National Group	$	7,506		$	7,056
American Group		6,616			6,291
Corporate and other		823			630
	$	14,945		$	13,977
Equity in earnings of affiliates:
National Group	$	(1	)	$	(7	)
American Group		(9	)		(12	)
Corporate and other		(1	)		(2	)
	$	(11	)	$	(21	)
Adjusted segment EBITDA:
National Group	$	1,566		$	1,705
American Group		1,486			1,501
Corporate and other		(108	)		(154	)
	$	2,944		$	3,052
Depreciation and amortization:
National Group	$	355		$	323
American Group		301			293
Corporate and other		76			81
	$	732		$	697
Adjusted segment EBITDA	$	2,944		$	3,052
Depreciation and amortization		732			697
Interest expense		408			384
Gains on sales of facilities		(10	)		(2	)
Income before income taxes	$	1,814		$	1,973

This quarterly report on Form 10-Q includes certain disclosures which contain “forward-looking statements” within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include statements regarding expected share-based compensation expense, expected capital expenditures and expected net claim payments and all other statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) developments related to COVID-19, including, without limitation, the length and severity of its impact and the spread of virus strains with new epidemiological characteristics; the volume of canceled or rescheduled procedures and the volume of COVID-19 patients cared for across our health systems; measures we are taking to respond to COVID-19; the impact and terms of government and administrative regulation and stimulus and relief measures (including the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act, the Paycheck Protection Program and Health Care Enhancement Act, the Consolidated Appropriations Act, 2021, the American Rescue Plan Act of 2021 (“ARPA”) and other enacted and potential future legislation) and whether various stimulus and relief programs continue or new similar programs are enacted in the future; changes in revenues due to declining patient volumes, changes in payer mix and deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients); potential increased expenses related to labor, supply chain or other expenditures; workforce disruptions, including the impact of any current or future vaccine mandates; supply shortages and disruptions; and the timing, availability and adoption of effective medical treatments and vaccines (including boosters), (2) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of COVID-19, which could impact us from a financial perspective, (3) the impact of current and future federal and state health reform initiatives and possible changes to other federal, state or local laws and regulations affecting the health care industry, including but not limited to, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Affordable Care Act”), and the effects of additional changes to the Affordable Care Act, its implementation, or interpretation (including through executive orders and court challenges), and proposals to expand coverage of federally-funded insurance programs as an alternative to private insurance or establish a single-payer system (such reforms often referred to as “Medicare for All”), and also including any such laws or governmental regulations which are adopted in response to COVID-19, (4) the effects related to the implementation of sequestration spending reductions required under the Budget Control Act of 2011, related legislation extending these reductions and those required under the Pay-As-You-Go Act of 2010 (“PAYGO Act”) as a result of the federal budget deficit impact of the ARPA, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (5) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (6) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (7) possible changes in Medicare, Medicaid and other state programs, including Medicaid supplemental payment programs or Medicaid waiver programs, that may impact reimbursements to health care providers and insurers and the size of the uninsured or underinsured population, (8) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (9) the highly competitive nature of the health care business, (10) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under third-party payer agreements, the ability to enter into and renew third-party payer provider agreements on acceptable terms and the impact of consumer-driven health plans and physician utilization trends and practices, (11) the efforts of health insurers, health care providers, large employer groups and others to contain health care costs, (12) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (13) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (14) changes in accounting practices, (15) changes in general economic conditions nationally and regionally in our markets, including inflation and economic and business conditions (and the impact thereof on the economy, financial markets and banking industry) resulting from COVID-19, (16) the emergence of and effects related to pandemics, epidemics and infectious diseases, (17) future divestitures which may result in charges and possible impairments of long-lived assets, (18) changes in business strategy or development plans, (19) delays in receiving payments for services provided, (20) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (21) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (22) the impact of potential cybersecurity incidents or security breaches, (23) our ongoing ability to demonstrate meaningful use of certified electronic health record (“EHR”) technology and the impact of interoperability requirements, (24) the impact of natural disasters, such as hurricanes and floods, physical risks from climate change or similar events beyond our control, (25) changes in U.S. federal, state, or foreign tax laws including interpretive guidance that may be issued by taxing authorities or other standard setting bodies, and (26) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2021 and our other filings with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report, which forward-looking statements reflect management’s views only as of the date of this report. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

Revenues increased to $14.945 billion in the first quarter of 2022 from $13.977 billion in the first quarter of 2021. Net income attributable to HCA Healthcare, Inc. totaled $1.273 billion, or $4.14 per diluted share, for the quarter ended March 31, 2022, compared to $1.423 billion, or $4.14 per diluted share, for the quarter ended March 31, 2021. First quarter results for 2022 include gains on sales of facilities of $10 million, or $0.02 per diluted share. In March 2022, the state of Texas received approval from the Centers for Medicare & Medicaid Services ("CMS") to implement a proposed directed payment program effective for the current program year that began September 1, 2021. During the first quarter of 2022, revenues include $244 million and other operating expenses include $90 million from provider tax assessments related to this program for the period September through December 2021. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 307.374 million shares for the quarter ended March 31, 2022 and 343.321 million shares for the quarter ended March 31, 2021. During 2021 and the first quarter of 2022, we repurchased 37.812 million shares and 8.375 million shares, respectively, of our common stock.

Revenues increased 6.9% on a consolidated basis and 7.8% on a same facility basis for the quarter ended March 31, 2022, compared to the quarter ended March 31, 2021. The increase in consolidated revenues can be primarily attributed to the combined impact of a 3.6% increase in revenue per equivalent admission and a 3.2% increase in equivalent admissions. The same facility revenues increase primarily resulted from the combined impact of a 2.7% increase in same facility revenue per equivalent admission and a 5.0% increase in same facility equivalent admissions. The consolidated and same facility increases in revenue per equivalent admission were negatively impacted by declines in acuity of COVID-19 patients.

During the quarter ended March 31, 2022, consolidated admissions increased 0.1% and same facility admissions increased 2.1% compared to the quarter ended March 31, 2021. Surgeries increased 4.3% on a consolidated basis and 4.6% on a same facility basis during the quarter ended March 31, 2022, compared to the quarter ended March 31, 2021. Emergency department visits increased 11.7% on a consolidated basis and 14.6% on a same facility basis during the quarter ended March 31, 2022, compared to the quarter ended March 31, 2021. Consolidated and same facility uninsured admissions declined 4.9% and 3.0%, respectively, for the quarter ended March 31, 2022, compared to the quarter ended March 31, 2021.

Cash flows from operating activities declined $643 million, from $1.988 billion for the first quarter of 2021 to $1.345 billion for the first quarter of 2022. The decline in cash provided by operating activities was primarily related to the combined impact of negative changes in working capital items of $492 million, primarily related to a payment of $344 million for deferred payroll taxes from 2020, and a $121 million decline in net income, excluding gains on sales of facilities.

Revenues increased 6.9% from $13.977 billion in the first quarter of 2021 to $14.945 billion in the first quarter of 2022. Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period from September through December 2021, related to the March 2022 CMS approval of a Texas directed payment program for the current program year that began September 1, 2021. Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payers. Estimates of contractual adjustments under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect. Patients treated at our hospitals for non-elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Our revenues by primary third-party payer classification and other (including uninsured patients) for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions):

	2022				2021
Medicare	$	2,726	18.2	%	$	2,559	18.3	%
Managed Medicare		2,324	15.6			2,053	14.7
Medicaid		579	3.9			527	3.8
Managed Medicaid		1,110	7.4			725	5.2
Managed care and insurers		7,152	47.9			6,885	49.1
International (managed care and insurers)		356	2.4			333	2.4
Other		698	4.6			895	6.5
Revenues	$	14,945	100.0	%	$	13,977	100.0	%

Consolidated and same facility revenue per equivalent admission increased 3.6% and 2.7%, respectively, in the first quarter of 2022, compared to the first quarter of 2021. Consolidated and same facility equivalent admissions increased 3.2% and 5.0%, respectively, in the first quarter of 2022, compared to the first quarter of 2021. Consolidated and same facility outpatient surgeries increased 7.0% and 6.8%, respectively, in the first quarter of 2022, compared to the first quarter of 2021. Consolidated and same facility inpatient surgeries declined 0.6% and increased 0.8%, respectively, in the first quarter of 2022, compared to the first quarter of 2021. Consolidated and same facility emergency department visits increased 11.7% and 14.6%, respectively, in the first quarter of 2022, compared to the first quarter of 2021.

	2022			2021
Patient care costs (salaries and benefits, supplies, other operating expense and depreciation<br> and amortization)	$	12,744		$	11,643
Cost-to-charges ratio (patient care costs as percentage of gross patient charges)		11.3	%		11.4	%
Total uncompensated care	$	7,005		$	6,821
Multiply by the cost-to-charges ratio		11.3	%		11.4	%
Estimated cost of total uncompensated care	$	792		$	778

Same facility uninsured admissions declined by 1,030 admissions, or 3.0%, in the first quarter of 2022 compared to the first quarter of 2021. Same facility uninsured admissions in 2021, compared to 2020, declined 6.3% in the fourth quarter, increased 1.2% in the third quarter, increased 6.6% in the second quarter of 2021, and declined 15.7% in the first quarter. The fluctuations in quarterly same facility admissions were primarily due to reimbursements received, as provided for under the Families First Coronavirus Response Act and subsequent legislation, for uninsured patients diagnosed with COVID-19 and the resulting classification of those patients as insured admissions, as well as general fluctuations in patient volumes resulting from COVID-19's impact on our operations. The government program to reimburse for testing and treatment of uninsured COVID-19 patients stopped accepting claims in March 2022.

The approximate percentages of our admissions related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and insurers and the uninsured for the quarters ended March 31, 2022 and 2021 are set forth in the following table.


Medicare	23	%	24	%
Managed Medicare	23		22
Medicaid	5		5
Managed Medicaid	13		12
Managed care and insurers	30		30
Uninsured	6		7
	100	%	100	%

The approximate percentages of our inpatient revenues related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and insurers for the quarters ended March 31, 2022 and 2021 are set forth in the following table.

At March 31, 2022, we had 91 hospitals in the states of Texas and Florida. During the quarter ended March 31, 2022, 58% of our admissions and 50% of our revenues were generated by these hospitals. Uninsured admissions in Texas and Florida represented 75% of our uninsured admissions during the quarter ended March 31, 2022.

We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. The Texas Healthcare Transformation and Quality Improvement Program (“Texas Waiver Program”) currently operates pursuant to a Medicaid waiver. During April 2022, CMS withdrew its previous letter that challenged the approval and extension of the Texas Waiver Program, and the program is now approved and extended through September 2030. Our Texas Medicaid revenues included Texas Waiver Program supplemental revenues of $103 million and $138 million during the first quarters of 2022 and 2021, respectively. In March 2022, the state of Texas received approval from CMS to implement a proposed directed payment program effective for the current program year that began September 1, 2021. During the first quarter of 2022, revenues include $385 million related to this program for the period September 2021 through March 2022. We receive supplemental payments in several other states. We are aware these supplemental payment programs are currently being reviewed by certain state agencies and some states have made requests to CMS to replace their existing supplemental payment programs. It is possible these reviews and requests will result in the restructuring of such supplemental payment programs and could result in the payment programs being reduced or eliminated. Because deliberations about these programs are ongoing, we are unable to estimate the financial impact the program structure modifications, if any, may have on our results of operations.

We present certain metrics and statistical information that management uses when assessing our results of operations. We believe this information is useful to investors as it provides insight to how management evaluates operational performance and trends between reporting periods. Information on how these metrics and statistical information are defined is provided in the following tables summarizing operating results and operating data.

The following is a comparative summary of results of operations for the quarters ended March 31, 2022 and 2021 (dollars in millions):

	2022						2021
	Amount			Ratio			Amount			Ratio
Revenues	$	14,945			100.0		$	13,977			100.0
Salaries and benefits		6,939			46.4			6,301			45.1
Supplies		2,321			15.5			2,224			15.9
Other operating expenses		2,752			18.5			2,421			17.4
Equity in earnings of affiliates		(11	)		(0.1	)		(21	)		(0.2	)
Depreciation and amortization		732			5.0			697			5.0
Interest expense		408			2.7			384			2.7
Gains on sales of facilities		(10	)		(0.1	)		(2	)		—
		13,131			87.9			12,004			85.9
Income before income taxes		1,814			12.1			1,973			14.1
Provision for income taxes		349			2.3			393			2.8
Net income		1,465			9.8			1,580			11.3
Net income attributable to noncontrolling interests		192			1.3			157			1.1
Net income attributable to HCA Healthcare, Inc.	$	1,273			8.5		$	1,423			10.2
% changes from prior year:
Revenues		6.9	%					8.7	%
Income before income taxes		(8.1	)					143.6
Net income attributable to HCA Healthcare, Inc.		(10.6	)					145.0
Admissions(a)		0.1						(4.1	)
Equivalent admissions(b)		3.2						(6.4	)
Revenue per equivalent admission		3.6						16.1
Same facility % changes from prior year(c):
Revenues		7.8						9.0
Admissions(a)		2.1						(4.2	)
Equivalent admissions(b)		5.0						(6.5	)
Revenue per equivalent admission		2.7						16.6

(a) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(b) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(c) Same facility information excludes the operations of hospitals and their related facilities which were either acquired or divested during the current and prior period.

Revenues increased to $14.945 billion in the first quarter of 2022 from $13.977 billion in the first quarter of 2021. Net income attributable to HCA Healthcare, Inc. totaled $1.273 billion, or $4.14 per diluted share, for the quarter ended March 31, 2022, compared to $1.423 billion, or $4.14 per diluted share, for the quarter ended March 31, 2021. First quarter results for 2022 include gains on sales of facilities of $10 million, or $0.02 per diluted share. In March 2022, the state of Texas received approval from CMS to implement a proposed directed payment program effective for the current program year that began September 1, 2021. During the first quarter of 2022, revenues include $244 million and other operating expenses include $90 million from provider tax assessments related to this program for the period September through December 2021. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 307.374 million shares for the quarter ended March 31, 2022 and 343.321 million shares for the quarter ended March 31, 2021. During 2021 and the first quarter of 2022, we repurchased 37.812 million shares and 8.375 million shares, respectively, of our common stock.

Salaries and benefits, as a percentage of revenues, were 46.4% in the first quarter of 2022 and 45.1% in the first quarter of 2021. Salaries and benefits per equivalent admission increased 6.7% in the first quarter of 2022 compared to the first quarter of 2021. Same facility salaries and benefits per full time equivalent increased 7.7% for the first quarter of 2022 compared to the first quarter of 2021 as we continue to utilize certain contract, overtime and other premium rate labor costs to support our clinical staff and patients. We intend to reduce our utilization of and rates paid for premium rate labor, but the pace and amount of any expected future declines may be affected by labor market conditions and other factors.

Supplies, as a percentage of revenues, were 15.5% in the first quarter of 2022 and 15.9% in the first quarter of 2021. Supply costs per equivalent admission increased 1.1% in the first quarter of 2022 compared to the first quarter of 2021. Supply costs per equivalent admission increased 5.9% for medical devices and 2.5% for general medical and surgical items and declined 10.7% for pharmacy supplies in the first quarter of 2022 compared to the first quarter of 2021. The decline in pharmacy supplies is primarily related to certain COVID-19 therapies used in the surge of COVID-19 cases during the first quarter of 2021.

Other operating expenses, as a percentage of revenues, were 18.5% in the first quarter of 2022 and 17.4% in the first quarter of 2021. Other operating expenses is primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. We have seen inflation have a negative impact on certain of these expenses and expect inflationary pressures will continue to impact operating expenses in the future. Provisions for losses related to professional liability risks were $143 million and $134 million for the first quarters of 2022 and 2021, respectively. For the quarter ended March 31, 2022, other operating expenses included $90 million of Texas provider tax assessments for September through December 2021 related to CMS' March 2022 approval of a Texas directed payment program (effective for the current program year that began September 1, 2021).

Equity in earnings of affiliates was $11 million and $21 million in the first quarters of 2022 and 2021, respectively.

Depreciation and amortization increased $35 million, from $697 million in the first quarter of 2021 to $732 million in the first quarter of 2022. The increase in depreciation relates primarily to capital expenditures at our existing facilities.

Interest expense was $408 million in the first quarter of 2022 and $384 million in the first quarter of 2021. Our average debt balance was $35.798 billion for the first quarter of 2022 compared to $31.019 billion for the first quarter of 2021. The average effective interest rate for our long-term debt was 4.6% and 5.0%, respectively, for the quarters ended March 31, 2022 and 2021.

During the first quarters of 2022 and 2021, we recorded gains on sales of facilities of $10 million and $2 million, respectively.

The effective tax rates were 21.5% and 21.7% for the first quarters of 2022 and 2021, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Our provisions for income taxes for the first quarters of 2022 and 2021 included tax benefits of $64 million and $74 million, respectively, related to employee equity award settlements. Excluding the effect of these adjustments, the effective tax rate for the first quarters of 2022 and 2021 would have been 25.5% and 25.7%, respectively.

Net income attributable to noncontrolling interests increased from $157 million for the first quarter of 2021 to $192 million for the first quarter of 2022. The increase in net income attributable to noncontrolling interests related primarily to the operations of two of our Texas markets and our surgery centers.

Cash provided by operating activities totaled $1.345 billion in the first quarter of 2022 compared to $1.988 billion in the first quarter of 2021. The $643 million decline in cash provided by operating activities, in the first quarter of 2022 compared to the first quarter of 2021, related primarily to the combined impact of negative changes in working capital items of $492 million, primarily related to a payment of $344 million for deferred payroll taxes from 2020, and a $121 million decline in net income, excluding gains on sales of facilities. The combination of interest payments and net income tax payments in the first quarter of 2022 totaled $411 million, compared to the net combination of interest payments and income tax refunds in the first quarter of 2021 of $362 million. Working capital totaled $4.488 billion at March 31, 2022 and $3.960 billion at December 31, 2021.

Cash used in investing activities was $845 million in the first quarter of 2022 compared to $649 million in the first quarter of 2021. Excluding acquisitions, capital expenditures were $861 million in the first quarter of 2022 and $654 million in the first quarter of 2021. Planned capital expenditures are expected to approximate $4.2 billion in 2022. At March 31, 2022, there were projects under construction which had estimated additional costs to complete and equip over the next five years of approximately $4.5 billion. We expect to finance capital expenditures with internally generated and borrowed funds.

Cash provided by financing activities totaled $425 million in the first quarter of 2022, compared to cash used in financing activities of $2.104 billion in the first quarter of 2021. During the first quarter of 2022, net cash flows provided by financing activities included a net increase of $3.120 billion in our indebtedness, payment of dividends of $177 million, repurchase of common stock of $2.101 billion and distributions to noncontrolling interests of $171 million. During the first quarter of 2021, net cash flows used in financing activities included a net increase of $33 million in our indebtedness, payment of dividends of $169 million, repurchase of common stock of $1.527 billion and distributions to noncontrolling interests of $234 million.

We are a highly leveraged company with significant debt service requirements. Our debt totaled $37.696 billion at March 31, 2022. Our interest expense was $408 million for the first quarter of 2022 and $384 million for the first quarter of 2021.

In addition to cash flows from operations, available sources of capital include amounts available under our senior secured credit facilities ($6.435 billion and $5.075 billion available as of March 31, 2022 and April 30, 2022, respectively) and anticipated access to public and private debt markets.

Investments of our insurance subsidiaries, held to maintain statutory equity levels and to provide liquidity to pay claims, totaled $513 million and $541 million at March 31, 2022 and December 31, 2021, respectively. An insurance subsidiary maintained net reserves for professional liability risks of $134 million and $154 million at March 31, 2022 and December 31, 2021, respectively. Our facilities are insured by our insurance subsidiary for losses up to $75 million per occurrence; however, this coverage is generally subject, in most cases, to a $15 million per occurrence self-insured retention. Additionally, the insurance subsidiary has entered into reinsurance contracts providing reimbursement for a certain portion of losses in excess of self-insured retentions. Net reserves for the self-insured professional liability risks retained were $1.809 billion and $1.813 billion at March 31, 2022 and December 31, 2021, respectively. Claims payments, net of reinsurance recoveries, during the next 12 months are expected to approximate $482 million. We estimate that approximately $439 million of the expected net claim payments during the next 12 months will relate to claims subject to the self-insured retention.

During March 2022, we issued $6.000 billion aggregate principal amount of senior secured notes comprised of (i) $1.000 billion aggregate principal amount of 3 1/8% senior secured notes due 2027, (ii) $500 million aggregate principal amount of 3 3/8% senior secured notes due 2029, (iii) $2.000 billion aggregate principal amount of 3 5/8% senior secured notes due 2032, (iv) $500 million aggregate principal amount of 4 3/8% senior secured notes due 2042 and (v) $2.000 billion aggregate principal amount of 4 5/8% senior secured notes due 2052. During March 2022, we used a portion of the net proceeds to pay down our revolving credit facilities. During April 2022, we redeemed all $1.250 billion outstanding aggregate principal amount of our 4.75% senior secured notes due 2023 and provided a notice of our election to redeem all $1.250 billion outstanding aggregate principal amount of our 5.875% senior notes due 2023.

Management believes that cash flows from operations, amounts available under our senior secured credit facilities and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next 12 months.

HCA Inc., a direct wholly-owned subsidiary of HCA Healthcare, Inc., is the primary obligor under a substantial portion of our indebtedness, including our senior secured credit facilities, senior secured notes and senior unsecured notes. The senior secured notes and senior unsecured notes issued by HCA Inc. are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc. The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed on a senior secured basis by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility). For a list of subsidiary guarantors, see Exhibit 22 to this quarterly report on Form 10-Q.

The subsidiary guarantees rank senior in right of payment to all subordinated indebtedness of each subsidiary guarantor, equally in right of payment with all senior indebtedness of the subsidiary guarantors and are structurally subordinated in right of payment to all indebtedness and other liabilities of any nonguarantor subsidiaries of the subsidiary guarantors (other than indebtedness and liabilities owed to one of the subsidiary guarantors). The subsidiary guarantees are secured by first-priority liens on the subsidiary guarantors’ assets, subject to certain exceptions, that secure our senior secured cash flow credit facility on a first-priority basis. The subsidiary guarantees are secured by second-priority liens on the subsidiary guarantors’ assets that secure our senior secured asset-based revolving credit facility on a first-priority basis and our senior secured cash flow credit facility on a second-priority basis.

The subsidiary guarantees may be automatically and unconditionally released and discharged upon certain customary events, including in the event such guarantee is released under our senior secured credit facilities. The indentures governing the senior secured notes include a “savings clause” intended to limit each subsidiary guarantor’s obligations as necessary to prevent the guarantee from constituting a fraudulent conveyance under applicable law, which could reduce a subsidiary guarantor’s liability on its guarantee to zero. For further information regarding the guarantees, refer to the applicable indentures that are filed as exhibits to this quarterly report on Form 10-Q and our annual report on Form 10-K for the year ended December 31, 2021.

Summarized financial information is presented on a combined basis and transactions between the combining entities have been eliminated. Financial information for nonguarantor entities has been excluded. The summarized operating results information for the quarter ended March 31, 2022 and year ended December 31, 2021 and the summarized balance sheet information at March 31, 2022 and December 31, 2021, for HCA Healthcare, Inc., HCA Inc. and the subsidiary guarantors (the Parent, Subsidiary Issuer and Subsidiary Guarantors) follow (dollars in millions):

Quarter Ended March 31, 2022 and Year Ended December 31, 2021:
	Quarter			Year
	March 31, 2022			December 31, 2021
Revenues	$	8,728		$	34,889
Income before income taxes		1,155			6,061
Net income		920			4,666
Net income attributable to Parent, Subsidiary Issuer and Subsidiary Guarantors		896			4,564
At March 31, 2022 and December 31, 2021:
	March 31, 2022			December 31, 2021
Current assets	$	9,415		$	8,268
Property and equipment, net		16,040			15,559
Goodwill and other intangible assets		5,695			5,694
Total noncurrent assets		22,719			22,370
Total assets		32,134			30,638
Current liabilities		6,807			5,697
Long-term debt, net		35,769			33,904
Intercompany balances		3,668			3,423
Income taxes and other liabilities		744			1,053
Total noncurrent liabilities		40,722			38,912
Stockholders’ deficit attributable to Parent, Subsidiary Issuer and Subsidiary <br> Guarantors		(15,551	)		(14,124	)
Noncontrolling interests		156			153

The first-priority liens securing the subsidiary guarantees discussed above include liens on (i) substantially all of the capital stock of substantially all wholly owned first-tier subsidiaries of HCA Inc. or of the subsidiary guarantors (but limited to 65% of the stock of any such wholly owned first-tier subsidiary that is a foreign subsidiary), subject to certain limited exceptions, and (ii) substantially all indebtedness owing to HCA Inc. or to the subsidiary guarantors, including any and all intercompany indebtedness owed by HCA Healthcare, Inc. or any subsidiary thereof to HCA Inc., or any subsidiary guarantor. For a list of affiliates whose securities are pledged as collateral for the senior secured notes, see Exhibit 22 to this quarterly report on Form 10-Q.

Under the first lien intercreditor agreement, the administrative agent for the lenders under the cash flow credit facility, subject to the occurrence of certain events, has the exclusive right to direct foreclosures and take other actions with respect to these liens, and the trustee for the senior secured notes has no right to take any such actions. In certain circumstances, including upon certain events of default under the senior secured credit facilities and the senior secured notes, the collateral agent in respect of the cash flow credit facility and the senior secured notes could proceed against the collateral granted to it to secure such indebtedness, including the aforementioned pledged capital stock and pledged indebtedness, and require such collateral to be delivered to the collateral agent to the extent not already in its possession for purposes of perfecting the lien on such assets. For further information regarding the collateral, including events or circumstances that may require delivery of the collateral, refer to the applicable indentures, the first lien intercreditor agreement, the cash flow credit agreement and the pledge agreement that are filed as exhibits to this quarterly report on Form 10-Q and our annual report on Form 10-K for the year ended December 31, 2021.

There is no trading market for any of HCA Healthcare, Inc.’s affiliates whose securities are pledged as collateral for the senior secured notes.

Rule 13-02 of Regulation S-X requires the presentation of summarized financial information of the combined affiliates whose securities are pledged as collateral for the senior secured notes unless such information is not material. The rule provides that such information is not material if the assets, liabilities and results of operations of the combined affiliates whose securities are pledged as collateral are not materially different than the corresponding amounts presented in the consolidated financial statements of the Registrant. Healthtrust, Inc. — The Hospital Company (“Healthtrust”) is the first-tier subsidiary of HCA Inc., and the common stock of Healthtrust is pledged as collateral for the senior secured notes. Due to the corporate structure relationship of HCA Healthcare, Inc. and Healthtrust, all of HCA Healthcare, Inc.’s operating subsidiaries, including all other affiliates whose securities are pledged as collateral for the senior secured notes, are also subsidiaries of Healthtrust. The corporate structure relationship, combined with the application of push-down accounting in Healthtrust’s consolidated financial statements related to HCA Healthcare Inc.’s debt and financial instruments, mean that the assets, liabilities and results of operations of Healthtrust (and, therefore, of the combined affiliates whose securities are pledged as collateral for the senior secured notes) are not materially different than the corresponding amounts presented in the financial statements of HCA Healthcare, Inc. As a result, summarized financial information of affiliates whose securities are pledged as collateral for the senior secured notes is not required to be presented under Rule 13-02.

We are exposed to market risk related to changes in market values of securities. The investment securities held by our insurance subsidiaries were recorded at $513 million at March 31, 2022. These investments are carried at fair value, with changes in unrealized gains and losses that are not credit-related being recorded as adjustments to other comprehensive income. At March 31, 2022, we had net unrealized losses of $10 million on the insurance subsidiaries’ investments.

We are exposed to market risk related to market illiquidity. Investment securities held by our insurance subsidiaries could be impaired by the inability to access the capital markets. Should the insurance subsidiaries require significant amounts of cash in excess of normal cash requirements to pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. We may be required to recognize credit-related impairments on our investment securities in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue-specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income.

With respect to our interest-bearing liabilities, approximately $1.440 billion of long-term debt at March 31, 2022 was subject to variable rates of interest, while the remaining balance of long-term debt of $36.256 billion at March 31, 2022 was subject to fixed rates of interest. Both the general level of interest rates and our leverage affect our variable interest rates. Our variable debt is comprised primarily of amounts outstanding under the senior secured credit facilities. Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% or (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period. The applicable margin for borrowings under the senior secured credit facilities may fluctuate according to a leverage ratio. The average effective interest rate for our long-term debt was 4.6% and 5.0% for the quarters ended March 31, 2022 and 2021, respectively.

The estimated fair value of our total long-term debt was $39.038 billion at March 31, 2022. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $14 million. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.

We are exposed to currency translation risk related to our foreign operations. We currently do not consider the market risk related to foreign currency translation to be material to our consolidated financial statements or our liquidity.

At March 31, 2022, the Internal Revenue Service was conducting examinations of the Company’s 2016, 2017 and 2018 federal income tax returns and the 2019 return for one affiliated partnership. We are also subject to examination by state and foreign taxing authorities. Management believes HCA Healthcare, Inc. and its predecessors, subsidiaries and affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with IRS, state and foreign taxing authorities and final resolution of any disputes will not have a material, adverse effect on our results of operations or financial position. However, if payments due upon final resolution of any issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.


Number of hospitals in operation at:
March 31	182	186
June 30		187
September 30		183
December 31		182
Number of freestanding outpatient surgical centers in operation at:
March 31	124	121
June 30		122
September 30		123
December 31		125
Licensed hospital beds at(a):
March 31	48,892	49,561
June 30		49,693
September 30		48,950
December 31		48,803
Weighted average beds in service(b):
Quarter:
First	41,818	42,363
Second		42,464
Third		42,088
Fourth		41,685
Year		42,148
Average daily census(c):
Quarter:
First	29,797	29,678
Second		28,901
Third		31,144
Fourth		29,273
Year		29,752
Admissions(d):
Quarter:
First	506,956	506,380
Second		532,041
Third		536,848
Fourth		514,706
Year		2,089,975
Equivalent admissions(e):
Quarter:
First	859,290	832,489
Second		916,212
Third		905,627
Fourth		881,910
Year		3,536,238
Average length of stay (days)(f):
Quarter:
First	5.3	5.3
Second		4.9
Third		5.3
Fourth		5.2
Year		5.2


Emergency room visits(g):
Quarter:
First	2,056,389		1,841,778
Second			2,128,428
Third			2,338,180
Fourth			2,166,959
Year			8,475,345
Outpatient surgeries(h):
Quarter:
First	247,421		231,228
Second			262,107
Third			249,192
Fourth			265,709
Year			1,008,236
Inpatient surgeries(i):
Quarter:
First	126,880		127,590
Second			136,460
Third			126,436
Fourth			131,583
Year			522,069
Days revenues in accounts receivable(j):
Quarter:
First	51		48
Second			48
Third			51
Fourth			49
Outpatient revenues as a % of patient revenues(k):
Quarter:
First	37	%	36	%
Second			38	%
Third			34	%
Fourth			38	%
Year			37	%

(a) Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.

(b) Represents the average number of beds in service, weighted based on periods owned.

(d) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(e) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume.

(f) Represents the average number of days admitted patients stay in our hospitals.

(g) Represents the number of patients treated in our emergency rooms.

(h) Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.

(i) Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

(j) Revenues per day is calculated by dividing revenues for the quarter by the days in the quarter. Days revenues in accounts receivable is then calculated as accounts receivable at the end of the quarter divided by revenues per day.

(k) Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.

The information called for by this item is provided under the caption “Market Risk” under Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

HCA’s management, with the participation of HCA’s chief executive officer and chief financial officer, has evaluated the effectiveness of HCA’s disclosure controls and procedures as of March 31, 2022. Based on that evaluation, HCA’s chief executive officer and chief financial officer concluded that HCA’s disclosure controls and procedures were effective as of March 31, 2022.

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

The information set forth in Note 9 – Contingencies in the notes to the condensed consolidated financial statements is incorporated herein by reference.

Reference is made to the factors set forth under the caption “Forward-Looking Statements” in Part I, Item 2 of this quarterly report on Form 10-Q and other risk factors described in our annual report on Form 10-K for the year ended December 31, 2021, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our annual report on Form 10-K for the year ended December 31, 2021.

During January 2022 and February 2021, our Board of Directors authorized share repurchase programs for up to $8 billion and $6 billion, respectively, of our outstanding common stock. During the quarter ended March 31, 2022, we repurchased 8,374,934 shares of our common stock at an average price of $250.89 per share through market purchases pursuant to the February 2021 authorization (which was completed during the first quarter of 2022) and the January 2022 authorization. At March 31, 2022, we had $6.485 billion of repurchase authorization available under the January 2022 authorization.

The following table provides certain information with respect to our repurchases of common stock from January 1, 2022 through March 31, 2022 (dollars in millions, except per share amounts).

Period		Average Price<br>Paid per Share			Approximate<br>Dollar Value of<br>Shares That<br>May Yet Be<br>Purchased<br>Under Publicly<br>Announced<br>Plans or<br>Programs
January 1, 2022 through January 31, 2022	2,347,430	$	249.68	2,347,430	$	8,000
February 1, 2022 through February 28, 2022	2,948,912	$	240.77	2,948,912	$	7,290
March 1, 2022 through March 31, 2022	3,078,592	$	261.49	3,078,592	$	6,485
Total for first quarter 2022	8,374,934	$	250.89	8,374,934	$	6,485

On April 21, 2022, our Board of Directors declared a quarterly dividend of $0.56 per share on our common stock payable on June 30, 2022 to stockholders of record at the close of business on June 16, 2022. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors. Our ability to declare future dividends may also from time to time be limited by the terms of our debt agreements.

(a) List of Exhibits:

4.1	—	Supplemental Indenture No. 29, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
4.2	—	Supplemental Indenture No. 30, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
4.3	—	Supplemental Indenture No. 31, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
4.4	—	Supplemental Indenture No. 32, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
4.5	—	Supplemental Indenture No. 33, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
4.6	—	Form of Global Notes representing the 2027 Notes (included in Exhibit 4.1)
4.7	—	Form of Global Notes representing the 2029 Notes (included in Exhibit 4.2)
4.8	—	Form of Global Notes representing the 2032 Notes (included in Exhibit 4.3)
4.9	—	Form of Global Notes representing the 2042 Notes (included in Exhibit 4.4)
4.10	—	Form of Global Notes representing the 2052 Notes (included in Exhibit 4.5)
4.11	—	Additional Receivables Intercreditor Agreement, dated as of March 9, 2022, by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as First Lien Collateral Agent (filed as Exhibit 4.15 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
4.12	—	Registration Rights Agreement, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein and Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the other several initial purchasers named therein (filed as Exhibit 4.16 to the Company’s Current Report on Form 8-K filed on March 10, 2022, and incorporated herein by reference).
10.1	—	HCA Healthcare, Inc. 2022 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 11, 2022, and incorporated herein by reference).*
22	—	List of Subsidiary Guarantors and Pledged Securities.
31.1	—	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
---	---	---
31.2	—	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	—	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	—	The following financial information from our quarterly report on Form 10-Q for the quarter ended March 31, 2022 filed with the SEC on May 3, 2022, formatted in Inline Extensible Business Reporting Language: (i) the condensed consolidated balance sheets at March 31, 2022 and December 31, 2021, (ii) the condensed consolidated income statements for the quarters ended March 31, 2022 and 2021, (iii) the condensed consolidated comprehensive income statements for the quarters ended March 31, 2022 and 2021, (iv) the condensed consolidated statements of stockholders’ equity for the quarters ended March 31, 2022 and 2021, (v) the condensed consolidated statements of cash flows for the quarters ended March 31, 2022 and 2021 and (vi) the notes to condensed consolidated financial statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104	—	The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in Inline XBRL (included in Exhibit 101).

*Management compensatory plan or arrangement.

Managed Medicare

Managed Medicaid

Managed care and insurers

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HCA Healthcare, Inc.
By:	/S/ WILLIAM B. RUTHERFORD
	William B. Rutherford
	Executive Vice President and Chief Financial Officer

Date: May 3, 2022

EX-22

Exhibit 22

List of Subsidiary Guarantors

All of the senior secured notes and senior unsecured notes issued by HCA Inc. are fully and unconditionally guaranteed by HCA Healthcare, Inc. In addition to the guarantee provided by HCA Healthcare, Inc., all of HCA Inc.’s senior secured notes are fully and unconditionally guaranteed by the subsidiary guarantors listed below.

American Medicorp Development Co.

Bay Hospital, Inc.

Brigham City Community Hospital, Inc.

Brookwood Medical Center of Gulfport, Inc.

Capital Division, Inc.

CarePartners HHA Holdings, LLLP

CarePartners HHA, LLLP

CarePartners Rehabilitation Hospital, LLLP

Centerpoint Medical Center of Independence, LLC

Central Florida Regional Hospital, Inc.

Central Shared Services, LLC

Central Tennessee Hospital Corporation

CHCA Bayshore, L.P.

CHCA Conroe, L.P.

CHCA Mainland, L.P.

CHCA Pearland, L.P.

CHCA West Houston, L.P.

CHCA Woman’s Hospital, L.P.

Chippenham & Johnston-Willis Hospitals, Inc.

Citrus Memorial Hospital, Inc.

Citrus Memorial Property Management, Inc.

Clinical Education Shared Services, LLC

Colorado Health Systems, Inc.

Columbia ASC Management, L.P.

Columbia Florida Group, Inc.

Columbia Healthcare System of Louisiana, Inc.

Columbia Jacksonville Healthcare System, Inc.

Columbia LaGrange Hospital, LLC

Columbia Medical Center of Arlington Subsidiary, L.P.

Columbia Medical Center of Denton Subsidiary, L.P.

Columbia Medical Center of Las Colinas, Inc.

Columbia Medical Center of Lewisville Subsidiary, L.P.

Columbia Medical Center of McKinney Subsidiary, L.P.

Columbia Medical Center of Plano Subsidiary, L.P.

Columbia North Hills Hospital Subsidiary, L.P.

Columbia Ogden Medical Center, Inc.

Columbia Parkersburg Healthcare System, LLC

Columbia Physician Services - Florida Group, Inc.

Columbia Plaza Medical Center of Fort Worth Subsidiary, L.P.

Columbia Rio Grande Healthcare, L.P.

Columbia Riverside, Inc.

Columbia Valley Healthcare System, L.P.

Columbia/Alleghany Regional Hospital Incorporated

Columbia/HCA John Randolph, Inc.

Columbine Psychiatric Center, Inc.

Columbus Cardiology, Inc.

Conroe Hospital Corporation

Cy-Fair Medical Center Hospital, LLC

Dallas/Ft. Worth Physician, LLC

Davie Medical Center, LLC

Dublin Community Hospital, LLC

East Florida - DMC, Inc.

Eastern Idaho Health Services, Inc.

Edward White Hospital, Inc.

El Paso Surgicenter, Inc.

Encino Hospital Corporation, Inc.

EP Health, LLC

Fairview Park GP, LLC

Fairview Park, Limited Partnership

FMH Health Services, LLC

Frankfort Hospital, Inc.

Galen Property, LLC

GenoSpace, LLC

Good Samaritan Hospital, L.P.

Goppert-Trinity Family Care, LLC

GPCH-GP, Inc.

Grand Strand Regional Medical Center, LLC

Green Oaks Hospital Subsidiary, L.P.

Greenview Hospital, Inc.

H2U Wellness Centers, LLC

HCA - IT&S Field Operations, Inc.

HCA - IT&S Inventory Management, Inc.

HCA American Finance LLC

HCA Central Group, Inc.

HCA Eastern Group, Inc.

HCA Health Services of Florida, Inc.

HCA Health Services of Louisiana, Inc.

HCA Health Services of Tennessee, Inc.

HCA Health Services of Virginia, Inc.

HCA Management Services, L.P.

HCA Pearland GP, Inc.

HCA Realty, Inc.

HCA-HealthONE LLC

HD&S Successor, LLC

Health Midwest Office Facilities Corporation

Health Midwest Ventures Group, Inc.

HealthTrust Workforce Solutions, LLC

Hendersonville Hospital Corporation

hInsight-Mobile Heartbeat Holdings, LLC

Hospital Corporation of Tennessee

Hospital Corporation of Utah

Hospital Development Properties, Inc.

Houston - PPH, LLC

Houston NW Manager, LLC

HPG Enterprises, LLC

HSS Holdco, LLC

HSS Systems, LLC

HSS Virginia, L.P.

HTI Memorial Hospital Corporation

HTI MOB, LLC

Integrated Regional Lab, LLC

Integrated Regional Laboratories, LLP

JFK Medical Center Limited Partnership

JPM AA Housing, LLC

KPH-Consolidation, Inc.

Lakeview Medical Center, LLC

Largo Medical Center, Inc.

Las Encinas Hospital

Las Vegas Surgicare, Inc.

Lawnwood Medical Center, Inc.

Lewis-Gale Hospital, Incorporated

Lewis-Gale Medical Center, LLC

Lewis-Gale Physicians, LLC

Lone Peak Hospital, Inc.

Los Robles Regional Medical Center

Management Services Holdings, Inc.

Marietta Surgical Center, Inc.

Marion Community Hospital, Inc.

MCA Investment Company

Medical Centers of Oklahoma, LLC

Medical Office Buildings of Kansas, LLC

MediCredit, Inc.

Memorial Healthcare Group, Inc.

MH Angel Medical Center, LLLP

MH Blue Ridge Medical Center, LLLP

MH Highlands-Cashiers Medical Center, LLLP

MH Hospital Holdings, Inc.

MH Hospital Manager, LLC

MH Master Holdings, LLLP

MH Master, LLC

MH Mission Hospital McDowell, LLLP

MH Mission Hospital, LLLP

MH Mission Imaging, LLLP

MH Transylvania Regional Hospital, LLLP

Midwest Division - ACH, LLC

Midwest Division - LSH, LLC

Midwest Division - MCI, LLC

Midwest Division - MMC, LLC

Midwest Division - OPRMC, LLC

Midwest Division - RBH, LLC

Midwest Division - RMC, LLC

Midwest Holdings, Inc.

Mobile Heartbeat, LLC

Montgomery Regional Hospital, Inc.

Mountain Division - CVH, LLC

Mountain View Hospital, Inc.

Nashville Shared Services General Partnership

National Patient Account Services, Inc.

New Iberia Healthcare, LLC

New Port Richey Hospital, Inc.

New Rose Holding Company, Inc.

North Florida Immediate Care Center, Inc.

North Florida Regional Medical Center, Inc.

North Houston - TRMC, LLC

North Texas - MCA, LLC

Northern Utah Healthcare Corporation

Northern Virginia Community Hospital, LLC

Northlake Medical Center, LLC

Notami Hospitals of Louisiana, Inc.

Notami Hospitals, LLC

Okaloosa Hospital, Inc.

Okeechobee Hospital, Inc.

Oklahoma Holding Company, LLC

Outpatient Cardiovascular Center of Central Florida, LLC

Outpatient Services Holdings, Inc.

Oviedo Medical Center, LLC

Palms West Hospital Limited Partnership

Parallon Business Solutions, LLC

Parallon Enterprises, LLC

Parallon Health Information Solutions, LLC

Parallon Holdings, LLC

Parallon Payroll Solutions, LLC

Parallon Physician Services, LLC

Parallon Revenue Cycle Services, Inc.

Pasadena Bayshore Hospital, Inc.

Pearland Partner, LLC

Plantation General Hospital, L.P.

Poinciana Medical Center, Inc.

Primary Health, Inc.

PTS Solutions, LLC

Pulaski Community Hospital, Inc.

Putnam Community Medical Center of North Florida, LLC

Reston Hospital Center, LLC

Retreat Hospital, LLC

Rio Grande Regional Hospital, Inc.

Riverside Healthcare System, L.P.

Riverside Hospital, Inc.

Samaritan, LLC

San Jose Healthcare System, LP

San Jose Hospital, L.P.

San Jose Medical Center, LLC

San Jose, LLC

Sarah Cannon Research Institute, LLC

Sarasota Doctors Hospital, Inc.

Savannah Health Services, LLC

SCRI Holdings, LLC

Sebring Health Services, LLC

SJMC, LLC

Southeast Georgia Health Services, LLC

Southern Hills Medical Center, LLC

Southpoint, LLC

Spalding Rehabilitation L.L.C.

Spotsylvania Medical Center, Inc.

Spring Branch Medical Center, Inc.

Spring Hill Hospital, Inc.

Springfield Health Services, LLC

SSHR Holdco, LLC

Sun City Hospital, Inc.

Sunrise Mountainview Hospital, Inc.

Surgicare of Brandon, Inc.

Surgicare of Florida, Inc.

Surgicare of Houston Women’s, Inc.

Surgicare of Manatee, Inc.

Surgicare of Newport Richey, Inc.

Surgicare of Palms West, LLC

Surgicare of Riverside, LLC

Tallahassee Medical Center, Inc.

TCMC Madison-Portland, Inc.

Terre Haute Hospital GP, Inc.

Terre Haute Hospital Holdings, Inc.

Terre Haute MOB, L.P.

Terre Haute Regional Hospital, L.P.

The Regional Health System of Acadiana, LLC

Timpanogos Regional Medical Services, Inc.

Trident Medical Center, LLC

U.S. Collections, Inc.

Utah Medco, LLC

VH Holdco, Inc.

VH Holdings, Inc.

Virginia Psychiatric Company, Inc.

Vision Consulting Group LLC

Vision Holdings, LLC

Walterboro Community Hospital, Inc.

WCP Properties, LLC

Weatherford Health Services, LLC

Wesley Medical Center, LLC

West Florida - MHT, LLC

West Florida - PPH, LLC

West Florida Regional Medical Center, Inc.

West Valley Medical Center, Inc.

Western Plains Capital, Inc.

WHMC, Inc.

Woman’s Hospital of Texas, Incorporated

List of Pledged Securities

The subsidiary guarantees discussed above are secured by first-priority liens on substantially all of the capital stock of substantially all wholly owned first-tier subsidiaries of HCA Inc. or of subsidiary guarantors (but limited to 65% of the stock of any such wholly owned first-tier subsidiary that is a foreign subsidiary), subject to certain limited exceptions. Below is a list of all of the entities in which the identified credit party owns stock, partnership interest, limited liability company membership interest or other equity interest that is pledged as collateral for the senior secured notes.

Credit Party	Legal Entity Owned
American Medicorp Development Co.	CVMC Property, LLC<br><br>HCA-HealthONE LLC<br><br>Rapides Healthcare System, L.L.C.<br><br>Surgicare of Evans, Inc.
Brigham City Community Hospital, Inc.	Brigham City Community Hospital Physician Services, LLC<br><br>MountainStar Brigham General Surgery, LLC
Brookwood Medical Center of Gulfport, Inc.	Coastal Imaging Center of Gulfport, Inc.<br><br>EPIC Properties, Inc.<br><br>Garden Park Investments, L.P.<br><br>Garden Park Physician Group - Specialty Care, LLC<br><br>Garden Park Physician Group, Inc.<br><br>GPCH-GP, Inc.<br><br>Gulf Coast Medical Ventures, Inc.
Capital Division, Inc.	Capital Professional Billing, LLC<br><br>HCA LewisGale Regional Cancer Centers Clinical Co-Management Company, LLC
	Virginia Care Partners ACO LLC<br><br>Virginia Quality Care Partners, LLC
CarePartners HHA Holdings, LLLP	CarePartners HHA, LLLP
CarePartners Rehabilitation Hospital, LLLP	MH Anesthesiology Physicians, LLC<br><br>MH Physician Services, LLC<br><br>Mission Health Community Multispecialty Providers, LLC
Centerpoint Medical Center of Independence, LLC	The Regional Health System of Acadiana, LLC
Central Florida Regional Hospital, Inc.	Central Florida Cardiology Interpretations, LLC<br><br>JPM AA Housing, LLC
Central Shared Services, LLC	Clinical Education Shared Services, LLC
CHCA Bayshore, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Bayshore Medical Center, LLC
CHCA Conroe, L.P.	CRMC-M, LLC<br><br>HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Conroe Regional Medical Center, LLC
CHCA Pearland, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Pearland Medical Center, LLC
CHCA West Houston, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at West Houston Medical Center, LLC
---	---
CHCA Woman’s Hospital, L.P.	Fannin MOB Property Management, LLC<br><br>HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Woman’s Hospital of Texas, LLC
Chippenham & Johnston-Willis Hospitals, Inc.	CJW Wound Healing Center, LLC<br><br>Crewe Outpatient Imaging, LLC<br><br>Imaging Services of Richmond, LLC
Colorado Health Systems, Inc.	HealthONE of Denver, Inc.<br><br>New Rose Holding Company, Inc.
Columbia Florida Group, Inc.	Columbia Central Florida Division, Inc.<br><br>Columbia Physician Services - Florida Group, Inc.<br><br>Columbia Tampa Bay Division, Inc.<br><br>East Florida Division, Inc.<br><br>Fort Myers Market, Inc.<br><br>North Florida Division I, Inc.<br><br>West Florida Division, Inc.
Columbia Healthcare System of Louisiana, Inc.	Centerpoint Clinic of Blue Springs, LLC<br><br>Centerpoint Medical Center of Independence, LLC<br><br>Centerpoint Physicians Group, LLC<br><br>Centerpoint Women’s Services, LLC<br><br>Children’s Multi-Specialty Group, LLC<br><br>Columbia/HCA of Baton Rouge, Inc.<br><br>Lafayette OB Hospitalists, LLC<br><br>Lakeview Cardiology Specialists, LLC<br><br>Lakeview Regional Physician Group, LLC<br><br>Research Family Physicians, LLC<br><br>Southwest Medical Center Multi-Specialty Group, LLC<br><br>Southwest Medical Center Surgical Group, LLC<br><br>Tchefuncte Cardiology Associates - Lakeview, LLC<br><br>Women’s & Children’s Pediatric Hematology/Oncology Center, LLC Women’s Multi-Specialty Group, LLC
Columbia Jacksonville Healthcare System, Inc.	Memorial Family Practice Associates, LLC<br><br>Memorial Health Primary Care at St. Johns Bluff, LLC<br><br>Memorial Healthcare Group, Inc.<br><br>Memorial Neurosurgery Group, LLC
Columbia LaGrange Hospital, LLC	Kendall Regional Medical Center, LLC
Columbia Medical Center of Arlington Subsidiary, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Medical Center Arlington, LLC
---	---
Columbia Medical Center of Denton Subsidiary, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Denton Regional Medical Center, LLC
Columbia Medical Center of Las Colinas, Inc.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Las Colinas Medical Center, LLC<br><br>Tuscan Imaging Center at Las Colinas, LLC
Columbia Medical Center of Lewisville Subsidiary, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Medical Center of Lewisville, LLC
Columbia Medical Center of McKinney Subsidiary, L.P.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Medical Center of McKinney, LLC
Columbia Medical Center of Plano Subsidiary, L.P.	HCA-Solis Holdings, Inc.<br><br>Plano Ambulatory Surgery Associates, L.P.<br><br>Plano Heart Management, LLC<br><br>Plano Surgicenter Real Estate Manager, LLC<br><br>Solis Mammography at Medical Center of Plano, LLC
Columbia Ogden Medical Center, Inc.	MountainStar Cardiology Ogden Regional, LLC<br><br>Ogden Regional Medical Center Professional Billing, LLC<br><br>Ogden Senior Center, LLC
Columbia Parkersburg Healthcare System, LLC	Parkersburg SJ Holdings, Inc.
Columbia Physician Services - Florida Group, Inc.	Central Florida Division Practice, Inc.<br><br>North Florida Division Practice, Inc.<br><br>Premier Medical Management, Ltd.<br><br>South Florida Division Practice, Inc.
Columbia Riverside, Inc.	Riverside Healthcare System, L.P.
Columbia/Alleghany Regional Hospital Incorporated	Alleghany Primary Care, Inc.<br><br>Alleghany Specialists, LLC
Columbia/HCA John Randolph, Inc.	Imaging Services of Appomattox, LLC
Columbine Psychiatric Center, Inc.	HCA-HealthONE LLC
Conroe Hospital Corporation	CHCA Conroe, L.P.<br><br>Conroe Partner, LLC
---	---
Dublin Community Hospital, LLC	Fairview Park GP, LLC<br><br>Fairview Partner, LLC
Eastern Idaho Health Services, Inc.	EIRMC Hospitalist Services, LLC
El Paso Surgicenter, Inc.	El Paso Surgery Centers, L.P.
EP Health, LLC	Brookwood Medical Center of Gulfport, Inc.<br><br>Coastal Healthcare Services, Inc.<br><br>Epic Diagnostic Centers, Inc.<br><br>Epic Healthcare Management Company<br><br>EPIC Surgery Centers, Inc.<br><br>Grace 1011, LLC<br><br>Health Insight Capital, LLC<br><br>MRT&C, Inc.<br><br>Primary Health Asset Holdings, Ltd.<br><br>PSG Delegated Services, LLC<br><br>SSHR Holdco, LLC
Fairview Park GP, LLC	Fairview Park, Limited Partnership
FMH Health Services, LLC	New Hampshire Imaging Services, Inc.
Frankfort Hospital, Inc.	Frankfort Wound Care, LLC
Galen Property, LLC	Henrico Doctors Hospital - Forest Campus Property, LLC
GPCH-GP, Inc.	Garden Park Community Hospital Limited Partnership
Grand Strand Regional Medical Center, LLC	Grand Strand Senior Health Center, LLC
Greenview Hospital, Inc.	Frankfort Hospital, Inc.<br><br>Southern Kentucky Surgicenter, LLC
H2U Wellness Centers, LLC	Health to You, LLC
HCA Central Group, Inc.	Capital Division, Inc.<br><br>HCA Chattanooga Market, Inc.<br><br>MidAmerica Division, Inc.<br><br>TriStar Health System, Inc.
HCA Eastern Group, Inc.	Columbia Florida Group, Inc.<br><br>South Atlantic Division, Inc.
HCA Health Services of Florida, Inc.	Bradenton Cardiology Physician Network, LLC<br><br>Hilltop 408, LLC<br><br>North Physician Services, Inc.<br><br>Oak Hill Acquisition, Inc.<br><br>St. Lucie Medical Center Hyperbarics, LLC<br><br>Surgicare of Bayonet Point, Inc.<br><br>West Florida Physician Network, LLC<br><br>West Florida Trauma Network, LLC<br><br>West Florida Urgent Care Network, LLC
HCA Health Services of Louisiana, Inc.	Cedar Creek Medical Group, LLC<br><br>Foot & Ankle Specialty Services, LLC<br><br>Goppert-Trinity Family Care, LLC<br><br>Midwest Cardiovascular & Thoracic Surgery, LLC<br><br>Midwest Division - LSH, LLC<br><br>Midwest Division - MCI, LLC<br><br>Midwest Division - RBH, LLC<br><br>Midwest Division - RMC, LLC<br><br>Midwest Trauma Services, LLC<br><br>Midwest Women’s Healthcare Specialists, LLC<br><br>Raymore Medical Group, LLC<br><br>RMC - Pulmonary, LLC<br><br>Senior Health Associates, LLC<br><br>Women’s Center at Brookside, LLC
---	---
HCA Health Services of Tennessee, Inc.	2490 Church, LLC<br><br>Centennial CyberKnife Center, LLC<br><br>Centennial Neuroscience, LLC<br><br>Centennial Surgical Clinic, LLC<br><br>Central Tennessee Hospital Corporation<br><br>HCA-Solis Holdings, Inc.<br><br>Hospitalists at Centennial Medical Center, LLC<br><br>Judson Holdings, LLC<br><br>Neuro Affiliates Company<br><br>Old Fort Village, LLC<br><br>Solis Mammography at StoneCrest Medical Center, LLC<br><br>Southpoint, LLC<br><br>Summit General Partner, Inc.<br><br>Summit Walk-In Clinic, LLC<br><br>Surgicare of Brentwood, LLC<br><br>TriStar Cardiovascular Surgery, LLC<br><br>TriStar Medical Group - Centennial Primary Care, LLC
HCA Health Services of Virginia, Inc.	Columbia Arlington Healthcare System, L.L.C.<br><br>Columbia/HCA John Randolph, Inc.<br><br>Preferred Hospitals, Inc.<br><br>Reston Hospital Center, LLC<br><br>Retreat Hospital, LLC<br><br>Spotsylvania Medical Center, Inc.<br><br>West Creek Ambulatory Surgery Center, LLC
HCA Inc.	HCA American Finance LLC<br><br>HCA Property GP, LLC<br><br>Healthtrust, Inc. – The Hospital Company<br><br>HSS Holdco, LLC
---	---
HCA Management Services, L.P.	Clinical Documentation, LLC<br><br>HCA Healthcare Marketing and Corporate Affairs, LLC<br><br>Healthcare Support Services, LLC
HCA Pearland GP, Inc.	CHCA Pearland, L.P.<br><br>Pearland Partner, LLC
HCA-HealthONE LLC	Altitude Mid Level Providers, LLC<br><br>Center for Advanced Diagnostics LLC<br><br>HCA-Solis Master, LLC<br><br>HealthONE at Breckenridge, LLC<br><br>HealthONE Aurora Investment, LLC<br><br>HealthONE Care Partners, LLC<br><br>HealthONE CareNow Urgent Care, LLC<br><br>HealthONE Clear Creek, LLC<br><br>HealthONE Clinic Services - Bariatric Medicine, LLC<br><br>HealthONE Clinic Services - Behavioral Health, LLC<br><br>HealthONE Clinic Services - Cardiovascular, LLC<br><br>HealthONE Clinic Services - Medical Specialties, LLC<br><br>HealthONE Clinic Services - Neurosciences, LLC<br><br>HealthONE Clinic Services - Obstetrics and Gynecology, LLC<br><br>HealthONE Clinic Services - Occupational Medicine, LLC<br><br>HealthONE Clinic Services - Oncology Hematology, LLC<br><br>HealthONE Clinic Services - Orthopedic Specialists, LLC<br><br>HealthONE Clinic Services - Otolaryngology Specialists, LLC<br><br>HealthONE Clinic Services - Pediatric Specialties, LLC<br><br>HealthONE Clinic Services - Primary Care, LLC<br><br>HealthONE Clinic Services - Spinal Cord Injury Institute, LLC<br><br>HealthONE Clinic Services - Surgery Neurological, LLC<br><br>HealthONE Clinic Services - Surgical Specialties, LLC<br><br>HealthONE Clinic Services - Youth Rehabilitation LLC<br><br>HealthONE Clinic Services LLC<br><br>HealthONE Heart Care LLC<br><br>HealthONE High Street Primary Care Center, LLC
	HealthONE IRL Pathology Services, LLC<br><br>HealthONE Lincoln Investment, LLC<br><br>HealthONE Lowry, LLC<br><br>HealthONE Radiation Therapy at Red Rocks, LLC<br><br>HealthONE Radiation Therapy at Thornton, LLC<br><br>HealthONE Surgicare of Ridge View, LLC<br><br>HealthONE Urologic, LLC<br><br>HealthONE Westside Investment, LLC<br><br>Hospital Cooperative Laundry, Inc.<br><br>Hospital Based CRNA Services, Inc.<br><br>HSS Inc.<br><br>Lakewood Surgicare, Inc.<br><br>Medical Care America Colorado, LLC<br><br>Medical Imaging of Colorado LLC<br><br>P/SL Hyperbaric Partnership<br><br>Proaxis Therapy HealthONE LLC<br><br>Rocky Mountain Pediatric Hematology Oncology, LLC<br><br>Rose Health Partners, LLC<br><br>Rose Medical Plaza, Ltd.<br><br>Rose POB, Inc.<br><br>Sky Ridge Spine Manager, LLC<br><br>Solis Mammography at Rose Medical Center, LLC<br><br>Spalding Rehabilitation, L.L.C.<br><br>Surgicare of Denver Mid-Town, Inc.<br><br>Surgicare of Rose, LLC<br><br>Surgicare of Sky Ridge, LLC<br><br>Surgicare of Southeast Denver, Inc.<br><br>Surgicare of Swedish, LLC<br><br>Surgicare of Thornton, LLC<br><br>Swedish Medpro, Inc.<br><br>Swedish MOB Acquisition, Inc.<br><br>Swedish MOB II, Inc.<br><br>Swedish MOB III, Inc.<br><br>Swedish MOB IV, Inc.
---	---
HD&S Successor, LLC	Plantation General Hospital, L.P.
Health Midwest Ventures Group, Inc.	Clinishare, Inc.<br><br>Eye Care Surgicare, Ltd., a Missouri Limited Partnership<br><br>HCA Midwest Comprehensive Care, Inc.<br><br>Health Midwest Medical Group, Inc.<br><br>Health Midwest Office Facilities Corporation<br><br>HM OMCOS, LLC<br><br>Johnson County Surgicenter, L.L.C.<br><br>Surgicenter of Kansas City, L.L.C.
HealthTrust Workforce Solutions, LLC	Martin Fletcher Associates Holdings, Inc.
---	---
hInsight-Mobile Heartbeat Holdings, LLC	Mobile Heartbeat, LLC
Hospital Development Properties, Inc.	Lafayette Medical Office Building, Ltd. (A partnership in Commendam)
HPG Enterprises, LLC	HCA Management Services, L.P.<br><br>Healthtrust Purchasing Group, L.P.<br><br>Valify, Inc.
HSS Holdco, LLC	HSS Virginia, L.P.<br><br>Nashville Shared Services General Partnership<br><br>Terre Haute MOB, L.P.
HSS Systems, LLC	HSS Virginia, L.P.<br><br>Nashville Shared Services General Partnership<br><br>Parallon Health Information Solutions, LLC<br><br>Parallon Payroll Solutions, LLC<br><br>Parallon Physician Services, LLC<br><br>Texas HSS, LLC
HSS Virginia, L.P.	Nashville Shared Services General Partnership
HTI Memorial Hospital Corporation	DAG Holdings, LLC<br><br>HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Skyline Medical Center, LLC
HTI MOB, LLC	Healthtrust MOB Tennessee, LLC<br><br>Medical Office Buildings of Kansas, LLC
Houston NW Manager, LLC	Houston Northwest Operating Company, L.L.C.
Integrated Regional Lab, LLC	Integrated Regional Laboratories, LLP
Integrated Regional Laboratories, LLP	Integrated Regional Laboratories Pathology Services, LLC
JFK Medical Center Limited Partnership	Palm Beach Hospitalists Program, LLC<br><br>AR Holding 5, LLC
KPH-Consolidation, Inc.	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Kingwood Medical Center, LLC
Las Encinas Hospital	L E Corporation
Las Vegas Surgicare, Inc.	Las Vegas Surgicare, Ltd., a Nevada Limited Partnership
Lewis-Gale Hospital, Incorporated	Columbia/Alleghany Regional Hospital Incorporated<br><br>Lewis-Gale Medical Center, LLC<br><br>Lewis-Gale Physicians, LLC<br><br>Roanoke Imaging, LLC<br><br>Roanoke Neurosurgery, LLC<br><br>Salem Hospitalists, LLC
Lewis-Gale Medical Center, LLC	Daleville Imaging Manager, LLC<br><br>Daleville Imaging, L.P.
Los Robles Regional Medical Center	Los Robles Regional Medical Center MOB, LLC<br><br>Los Robles Surgicenter, LLC<br><br>TODIC, L.P.
Management Services Holdings, Inc.	HPG Enterprises, LLC<br><br>HPG Solutions, LLC
---	---
Marietta Surgical Center, Inc.	Marietta Outpatient Surgery, Ltd.
MCA Investment Company	Columbia ASC Management, L.P.
Medical Centers of Oklahoma, LLC	EPIC Properties, Inc.<br><br>Medical Imaging, Inc.<br><br>SWMC, Inc.
Memorial Healthcare Group, Inc.	Jacksonville Surgery Center, Ltd.<br><br>MHS Partnership Holdings JSC, Inc.<br><br>MHS Partnership Holdings SDS, Inc.<br><br>MSL Acquisition, LLC
MH Hospital Holdings, Inc.	MH Asheville Specialty Hospital, LLC<br><br>MH Hospital Manager, LLC<br><br>MH Master Holdings, LLLP<br><br>Mission Employer Solutions, LLC<br><br>Mission Health Partners, Inc.
MH Hospital Manager, LLC	MH Master Holdings, LLLP
MH Master Holdings, LLLP	Assuring Affordable, Quality Healthcare in North Carolina, LLC<br><br>CarePartners HHA Holdings, LLLP<br><br>CarePartners Rehabilitation Hospital, LLLP<br><br>Imaging Realty LLC<br><br>MH Angel Medical Center, LLLP<br><br>MH Blue Ridge Medical Center, LLLP<br><br>MH Eckerd Living Center, LLLP<br><br>MH Highlands-Cashiers Medical Center, LLLP<br><br>MH Master, LLC<br><br>MH McDowell Imaging, LLLP<br><br>MH Mission Hospital McDowell, LLLP<br><br>MH Mission Hospital, LLLP<br><br>MH Mission Imaging, LLLP<br><br>MH Transylvania Imaging, LLLP<br><br>MH Transylvania Regional Hospital, LLLP<br><br>Provider-Led, Patient-Centered Care, LLC<br><br>Western North Carolina Healthcare Innovators, LLC
MH Master, LLC	CarePartners HHA Holdings, LLLP<br><br>CarePartners HHA, LLLP<br><br>CarePartners Rehabilitation Hospital, LLLP<br><br>MH Angel Medical Center, LLLP<br><br>MH Blue Ridge Medical Center, LLLP<br><br>MH Eckerd Living Center, LLLP<br><br>MH Highlands-Cashiers Medical Center, LLLP
	MH McDowell Imaging, LLLP<br><br>MH Mission Hospital McDowell, LLLP<br><br>MH Mission Hospital, LLLP<br><br>MH Mission Imaging, LLLP<br><br>MH Transylvania Imaging, LLLP<br><br>MH Transylvania Regional Hospital, LLLP
---	---
MH Mission Hospital, LLLP	WNC Stone Center, LLC
Midwest Division - OPRMC, LLC	Forward Pathology Solutions Wichita, LLC<br><br>Heartland Women’s Group at Wesley, LLC<br><br>Intensive Care Consortium-Midwest, LLC<br><br>Neurology Associates of Kansas, LLC<br><br>OPRMC-HBP, LLC<br><br>Wesley Physician Services, LLC<br><br>Wesley Physicians - Medical Specialties LLC<br><br>Wesley Urgent Care, LLC<br><br>Wichita CareNow Urgent Care, LLC
Midwest Division - RBH, LLC	Bone & Joint Specialists Physician Group, LLC
Midwest Division - RMC, LLC	RMC Transplant Physicians, LLC
Midwest Holdings, Inc.	Health Midwest Ventures Group, Inc.<br><br>Medical Center Imaging, Inc.<br><br>Midwest Division - ACH, LLC<br><br>Midwest Division - LRHC, LLC<br><br>Mill Creek Outpatient Services, LLC
Montgomery Regional Hospital, Inc.	Blacksburg Imaging, LLC<br><br>Montgomery Cancer Center, LLC
Mountain View Hospital, Inc.	MVH Professional Services, LLC<br><br>Timpanogos Regional Medical Services, Inc.
National Patient Account Services, Inc.	NPAS Solutions, LLC<br><br>NPAS, Inc.
New Iberia Healthcare, LLC	HTI MOB, LLC
New Rose Holding Company, Inc.	HCA-HealthONE LLC
North Florida Regional Medical Center, Inc.	HCA Imaging Services of North Florida, Inc.<br><br>Medical Partners of North Florida, LLC
North Houston - TRMC, LLC	HCA-Solis Holdings, Inc.<br><br>Solis Mammography at Houston Tomball, LLC
North Texas - MCA, LLC	Solis Mammography at Medical Center Alliance, LLC
Northern Utah Healthcare Corporation	Alta Internal Medicine, LLC<br><br>St. Mark’s Investments, Inc.
Notami Hospitals of Louisiana, Inc.	EPIC Properties, Inc.<br><br>Lakeview Medical Center, LLC
Notami Hospitals, LLC	CFC Investments, Inc.
	Columbia Good Samaritan Health System Limited Partnership<br><br>EPIC Properties, Inc.<br><br>Good Samaritan Hospital, LLC<br><br>Healdsburg General Hospital, Inc.<br><br>Mission Bay Memorial Hospital, Inc.<br><br>Samaritan, LLC<br><br>San Jose Medical Center, LLC<br><br>SJMC, LLC<br><br>South Valley Hospital, L.P.<br><br>West Lost Angeles Physicians’ Hospital, Inc.
---	---
Oklahoma Holding Company, LLC	Edmond General Surgery, LLC<br><br>Edmond Hospitalists, LLC<br><br>Healthcare Oklahoma, Inc.<br><br>Medi Flight of Oklahoma, LLC<br><br>Oklahoma Physicians - Medical Specialties LLC<br><br>Oklahoma Physicians - Obstetrics and Gynecology LLC<br><br>Oklahoma Physicians - Primary Care LLC<br><br>Oklahoma Physicians - Surgical Specialties LLC
Outpatient Services Holdings, Inc.	Eastern Idaho Brachytherapy Equipment Manager, LLC<br><br>HCA Outpatient Imaging Services Group, Inc.<br><br>HCA Research Institute, LLC<br><br>Healthcare Sales National Management Services Group, LLC<br><br>MidAmerica Oncology, LLC<br><br>Midtown Diagnostics, LLC<br><br>National Contact Center Management Group, LLC<br><br>National Transfer Center Management Services, LLC<br><br>North Hills Catheterization Lab, LLC<br><br>Ogden Tomotherapy Manager, LLC<br><br>Red Rock Holdco, LLC<br><br>Riverside CyberKnife Manager, LLC
Parallon Business Solutions, LLC	Central Shared Services, LLC<br><br>HealthTrust Workforce Solutions, LLC<br><br>HSS Systems, LLC<br><br>National Patient Account Services, Inc.<br><br>PTS Solutions, LLC<br><br>U.S. Collections, Inc.
Parallon Holdings, LLC	Parallon Business Solutions, LLC<br><br>Parallon Enterprises, LLC
Parallon Revenue Cycle Services, Inc.	MediCredit, Inc.
Pasadena Bayshore Hospital, Inc.	Bayshore Partner, LLC<br><br>CHCA Bayshore, L.P.
Pearland Partner, LLC	CHCA Pearland, L.P.
Primary Health, Inc.	Primary Health Asset Holdings, Ltd.
---	---
Regional Health System of Acadiana, LLC, The	RMCA Professionals Mgmt, LLC<br><br>Women’s & Children’s Pulmonology Clinic, LLC<br><br>Women’s and Children’s Professional Management, LLC
Reston Hospital Center, LLC	Ashburn Imaging, LLC<br><br>Generations Family Practice, Inc.<br><br>MRI of Reston Limited Partnership<br><br>Pavilion 2 Condominium Property, LLC<br><br>Reston Hospitalists, LLC
Retreat Hospital, LLC	Surgicare of Hanover, Inc.
Rio Grande Regional Hospital, Inc.	Columbia Rio Grande Healthcare, L.P.<br><br>Rio Grande Healthcare MSO, Inc.<br><br>Rio Grande NP, Inc.
Riverside Healthcare System, L.P.	Surgicare of Riverside, LLC
Riverside Hospital, Inc.	Bay Area Healthcare Group, Ltd.
Samaritan, LLC	Good Samaritan Hospital, L.P.
San Jose Medical Center, LLC	San Jose Hospital, L.P.
San Jose, LLC	San Jose Healthcare System, LP<br><br>San Jose Pathology Outreach, LLC
Sarasota Doctors Hospital, Inc.	Columbia Midtown Joint Venture
Savannah Health Services, LLC	4600 Waters Avenue Professional Building Condominium Association, Inc.<br><br>Georgia Eye Surgicenter, LLC<br><br>Provident Professional Building Condominium Association, Inc.<br><br>Savannah Center for Medical Education and Research, LLC<br><br>Wilmington Island Partners, LLC
SCRI Holdings, LLC	GenoSpace, LLC<br><br>Sarah Cannon Development Innovations, LLC<br><br>Sarah Cannon Research Institute, LLC<br><br>SCRI Global Services Limited<br><br>SCRI Scientifics, LLC<br><br>Summit Research Solutions, LLC
SJMC, LLC	San Jose Hospital, L.P.
Spotsylvania Medical Center, Inc.	Spotsylvania Condominium Property, LLC
SSHR Holdco, LLC	COSCORP, LLC<br><br>HCA Human Resources, LLC<br><br>Parallon Holdings, LLC
Surgicare of Brandon, Inc.	Bay Area Surgicenter, LLC
Surgicare of Florida, Inc.	Belleair Surgery Center, Ltd.
---	---
Surgicare of Houston Women’s, Inc.	Outpatient Women’s and Children’s Surgery Center, Ltd.
Surgicare of Manatee, Inc.	Manatee Surgicare, Ltd.
Surgicare of Newport Richey, Inc.	New Port Richey Surgery Center, Ltd.
Surgicare of Palms West, LLC	Palms West Surgery Center, Ltd.
Tallahassee Medical Center, Inc.	Banner Day Development, LLC
Terre Haute Hospital GP, Inc.	Terre Haute Regional Hospital, L.P.
Terre Haute Hospital Holdings, Inc.	Terre Haute Regional Hospital, L.P.
Terre Haute Regional Hospital, L.P.	Hospitalists of the Wabash Valley, LLC<br><br>Terre Haute MOB, L.P.<br><br>Terre Haute Obstetrics and Gynecology, LLC
Timpanogos Regional Medical Services, Inc.	MountainStar Intensivist Services, LLC<br><br>Timpanogos Pain Specialists, LLC
Trident Medical Center, LLC	Trident Behavioral Health Services, LLC<br><br>Trident Neonatology Services, LLC
U.S. Collections, Inc.	Parallon Revenue Cycle Services, Inc.
Utah Medco, LLC	Brigham City Community Hospital, Inc.<br><br>Brigham City Health Plan, Inc.<br><br>Columbia Ogden Medical Center, Inc.<br><br>Healthtrust Utah Management Services, Inc.<br><br>Hospital Corporation of Utah<br><br>HTI Physician Services of Utah, Inc.<br><br>Layton Family Practice, LLC<br><br>Mountain View Hospital, Inc.<br><br>MP Management, LLC<br><br>ODP Manager, LLC<br><br>Ogden Regional Health Plan, Inc.<br><br>Park View Insurance Company<br><br>Utah Holdco, LLC<br><br>WCP Properties, LLC<br><br>West Jordan Hospital Corporation
VH Holdco, Inc.	VH Holdings, Inc.
VH Holdings, Inc.	Center for Advanced Imaging, LLC<br><br>EMMC, LLC<br><br>FHAL, LLC<br><br>Galen GOK, LLC<br><br>Galen KY, LLC<br><br>Galen MCS, LLC<br><br>Galen MRMC, LLC<br><br>Galen NMC, LLC<br><br>Galen NSH, LLC<br><br>Galen SOM, LLC<br><br>Galen SSH, LLC
	HHNC, LLC<br><br>HPI Hospital Systems Management, Inc.<br><br>Notami, LLC<br><br>POH Holdings, LLC<br><br>Preferred Works WC, LLC<br><br>RCH, LLC<br><br>San Jose, LLC<br><br>Springview KY, LLC<br><br>Value Health Holdings, Inc.<br><br>Value Health Management, Inc.<br><br>WJHC, LLC
---	---
Virginia Psychiatric Company, Inc.	Columbia Arlington Healthcare System, L.L.C.
Vision Holdings, LLC	Vision Consulting Group LLC
Walterboro Community Hospital, Inc.	Colleton Medical Anesthesia, LLC<br><br>Colleton Medical Hospitalists, LLC
Weatherford Health Services, LLC	HCA-Solis Holdings, Inc.<br><br>Weatherford Mammography JV, LLC
Wesley Medical Center, LLC	Care for Women, LLC<br><br>Centerpoint Medical Specialists, LLC<br><br>College Park Ancillary, LLC<br><br>College Park Radiology, LLC<br><br>Emergency Physicians at Wesley Medical Center, LLC<br><br>Family Health Medical Group of Overland Park, LLC<br><br>Galichia Anesthesia Services, LLC<br><br>HCA Wesley Rehabilitation Hospital, Inc.<br><br>Health Partners of Kansas, Inc.<br><br>Hospitalists as Wesley Medical Center, LLC<br><br>IRL Pathology Services MidAmerica, LLC<br><br>Johnson County Neurology, LLC<br><br>Kansas CareNow Urgent Care, LLC<br><br>Kansas City Cardiac Arrhythmia Research LLC<br><br>Kansas City Gastroenterology & Hepatology Physicians Group, LLC<br><br>Kansas City Vascular & General Surgery Group, LLC<br><br>Kansas City Women’s Clinic Group, LLC<br><br>Kansas Pulmonary and Sleep Specialists, LLC<br><br>Kansas Trauma and Critical Care Specialists, LLC<br><br>Menorah Medical Group, LLC<br><br>Menorah Urgent Care, LLC<br><br>Midwest Cardiovascular and Thoracic Surgeons of Kansas, LLC<br><br>Midwest Division Spine Care, LLC
	Midwest Heart & Vascular Specialists, LLC<br><br>Midwest Oncology Associates, LLC<br><br>Overland Park Cardiovascular, Inc.<br><br>Overland Park Medical Specialists, LLC<br><br>Overland Park Orthopedics, LLC<br><br>Overland Park Surgical Specialties, LLC<br><br>Pediatric Specialty Clinic LLC<br><br>Quivira Internal Medicine, Inc.<br><br>Research Neurology Associates, LLC<br><br>Research Neuroscience Institute, LLC<br><br>Statland Medical Group, LLC<br><br>The Medical Group of Kansas City, LLC<br><br>Town Plaza Family Practice, LLC<br><br>Wesley Physicians - Anesthesiologist, LLC<br><br>Wesley Physicians - Cardiovascular, LLC<br><br>Wesley Physicians - Obstetrics and Gynecology LLC<br><br>Wesley Physicians - Primary Care LLC<br><br>Wesley Select Network, LLC
---	---
West Florida - PPH, LLC	SSJ St. Petersburg Holdings, Inc.
West Valley Medical Center, Inc.	Saint Alphonsus Caldwell Cancer Treatment Center, L.L.C.
Western Plains Capital, Inc.	C/HCA Capital, Inc.
WHMC, Inc.	CHCA West Houston, L.P.<br><br>West Houston, LLC
Woman’s Hospital of Texas, Incorporated	CHCA Woman’s Hospital, L.P<br><br>Houston Woman’s Hospital Partner, LLC<br><br>Woman’s Hospital Merger, LLC

The subsidiary guarantees discussed above are also secured by first-priority liens on substantially all indebtedness owing to HCA Inc. or to the subsidiary guarantors, including any and all intercompany indebtedness owed by HCA Healthcare, Inc. or any subsidiary thereof to HCA Inc., or any subsidiary guarantor.

Pursuant to the typical and customary cash management system established by HCA Healthcare, Inc., the affiliates of HCA Healthcare, Inc. listed below have entered into revolving promissory notes with Western Plains Capital, Inc., a subsidiary guarantor. The notes are pledged as collateral for the secured notes to the extent described above. Due to the revolving nature of the intercompany debt, the balance due from one party to another fluctuates based on cash activity from daily operations.

* Subsidiary guarantor.

AC Med, LLC

Acadiana Care Center, Inc.

Acadiana Practice Management, Inc.

Acadiana Regional Pharmacy, Inc.

ACH, Inc.

Advanced Bundle Convener, LLC

All About Staffing, LLC

Alleghany Primary Care, Inc.

Alliance Surgicare, LLC

Alternaco, LLC

Ambulatory Services Management Corporation of Chesterfield County, Inc.

*American Medicorp Development Co.

AOGN, LLC

AOSC Sports Medicine, Inc.

AR Holding 1, LLC

AR Holding 4, LLC

AR Holding 5, LLC

AR Holding 6, LLC

AR Holding 7, LLC

AR Holding 8, LLC

AR Holding 9, LLC

AR Holding 10, LLC

AR Holding 11, LLC

AR Holding 12, LLC

AR Holding 13, LLC

AR Holding 14, LLC

AR Holding 15, LLC

AR Holding 16, LLC

AR Holding 17, LLC

AR Holding 18, LLC

AR Holding 19, LLC

AR Holding 20, LLC

AR Holding 21, LLC

AR Holding 22, LLC

AR Holding 23, LLC

AR Holding 24, LLC

AR Holding 25, LLC

AR Holding 26, LLC

AR Holding 27, LLC

AR Holding 28, LLC

AR Holding 29, LLC

AR Holding 30, LLC

AR Holding 31, LLC

Arlington Diagnostic South, Inc.

Arlington Surgery Center, L.P.

Arlington Surgicare, LLC

ASD Shared Services, LLC

Ashburn ASC, LLC

Ashburn Imaging, LLC

Athens Community Hospital, Inc.

Atlanta Healthcare Management, L.P.

Atlanta Market GP, Inc.

Atlanta Outpatient Surgery Center, Inc.

Atlantis Surgicare, LLC

Atrium Surgery Center, L.P.

Atrium Surgicare, LLC

Augusta Management Services, LLC

Austin Medical Center, Inc.

Aventura Cancer Center Manager, LLC

Aventura Comprehensive Cancer Research Group of Florida, Inc.

Bailey Square Outpatient Surgical Center, Inc.

Basic American Medical, Inc.

Bay Area Healthcare Group, Ltd.

Bay Area Surgicare Center, Inc.

*Bay Hospital, Inc.

Bayshore Partner, LLC

Bedford-Northeast Community Hospital, Inc.

Bellaire Imaging, Inc.

Big Cypress Medical Center, Inc.

Bonita Bay Surgery Center, Inc.

Boynton Beach EFL Imaging Center, LLC

Bradenton Outpatient Services, LLC

Brandon Imaging Manager, LLC

Brandon Regional Cancer Center, LLC

*Brigham City Community Hospital, Inc.

Brigham City Health Plan, Inc.

*Brookwood Medical Center of Gulfport, Inc.

Broward Healthcare System, Inc.

Brownsville-Valley Regional Medical Center, Inc.

C/HCA Capital, Inc.

C/HCA Development, Inc.

C/HCA, Inc.

Calloway Creek Surgicare, LLC

Cancer Centers of North Florida, LLC

Cancer Services of Aventura, LLC

*Capital Division, Inc.

Capital Network Services, Inc.

CareOne Home Health Services, Inc.

*CarePartners HHA Holdings, LLLP

*CarePartners HHA, LLLP

*CarePartners Rehabilitation Hospital, LLLP

Carolina Regional Surgery Center, Inc.

CCH-GP, Inc.

Centennial CyberKnife Manager, LLC

Center for Advanced Imaging, LLC

*Centerpoint Medical Center of Independence, LLC

Central Florida Cardiology Interpretations, LLC

Central Florida Imaging Services, LLC

*Central Florida Regional Hospital, Inc.

Central Health Holding Company, Inc.

*Central Shared Services, LLC

*Central Tennessee Hospital Corporation

CFC Investments, Inc.

CH Systems

Chatsworth Hospital Corp.

Chattanooga Healthcare Network Partner, Inc.

CHC Finance Co.

CHC Holdings, Inc.

CHC Payroll Agent, Inc.

CHC Payroll Company

CHC Realty Company

CHC Venture Co.

*CHCA Bayshore, L.P.

CHCA Clear Lake, L.P.

*CHCA Conroe, L.P.

*CHCA Mainland, L.P.

*CHCA Pearland, L.P.

*CHCA West Houston, L.P.

*CHCA Woman’s Hospital, L.P.

CHC-El Paso Corp.

CHCK, Inc.

CHC-Miami Corp.

Chicago Grant Hospital, Inc.

Chino Community Hospital Corporation, Inc.

*Chippenham & Johnston-Willis Hospitals, Inc.

Chippenham Ambulatory Surgery Center, LLC

Chugach PT, Inc.

*Citrus Memorial Hospital, Inc.

*Citrus Memorial Property Management, Inc.

CLASC Manager, LLC

Clear Lake Cardiac Catheterization Center, L.P.

Clear Lake Cardiac GP, LLC

Clear Lake Merger, LLC

Clear Lake Regional Medical Center, Inc.

Clear Lake Regional Partner, LLC

*Clinical Education Shared Services, LLC

ClinicServ, LLC

Clinishare, Inc.

Coastal Bend Hospital, Inc.

Coastal Carolina Home Care, Inc.

Coastal Healthcare Services, Inc.

Coastal Imaging Center of Gulfport, Inc.

Coliseum Health Group, Inc.

Coliseum Park Hospital, Inc.

College Park Endoscopy Center, LLC

Colleton Ambulatory Care, LLC

Colleton Diagnostic Center, LLC

Collier County Home Health Agency, Inc.

*Colorado Health Systems, Inc.

Columbia Ambulatory Surgery Division, Inc.

*Columbia ASC Management, L.P.

Columbia Bay Area Realty, Ltd.

Columbia Behavioral Healthcare of South Florida, Inc.

Columbia Behavioral Healthcare, Inc.

Columbia Call Center, Inc.

Columbia Central Florida Division, Inc.

Columbia Central Group, Inc.

Columbia Champions Treatment Center, Inc.

Columbia Chicago Division, Inc.

Columbia Coliseum Same Day Surgery Center, Inc.

Columbia Development of Florida, Inc.

Columbia Doctors Hospital of Tulsa, Inc.

*Columbia Florida Group, Inc.

Columbia GP of Mesquite, Inc.

Columbia Greater Houston Division Healthcare Network, Inc.

Columbia Health System of Arkansas, Inc.

*Columbia Healthcare System of Louisiana, Inc.

Columbia Hospital at Medical City Dallas Subsidiary, L.P.

Columbia Hospital Corporation at the Medical Center

Columbia Hospital Corporation of Arlington

Columbia Hospital Corporation of Bay Area

Columbia Hospital Corporation of Central Miami

Columbia Hospital Corporation of Corpus Christi

Columbia Hospital Corporation of Fort Worth

Columbia Hospital Corporation of Houston

Columbia Hospital Corporation of Kendall

Columbia Hospital Corporation of Massachusetts, Inc.

Columbia Hospital Corporation of Miami

Columbia Hospital Corporation of Miami Beach

Columbia Hospital Corporation of North Miami Beach

Columbia Hospital Corporation of South Broward

Columbia Hospital Corporation of South Dade

Columbia Hospital Corporation of South Florida

Columbia Hospital Corporation of South Miami

Columbia Hospital Corporation of Tamarac

Columbia Hospital Corporation of West Houston

Columbia Hospital Corporation-Delaware

Columbia Hospital Corporation-SMM

Columbia Hospital-El Paso, Ltd.

Columbia Integrated Health Systems, Inc.

*Columbia LaGrange Hospital, LLC

Columbia Lake Worth Surgical Center Limited Partnership

Columbia Medical Arts Hospital Subsidiary, L.P.

Columbia Medical Center at Lancaster Subsidiary, L.P.

Columbia Medical Center Dallas Southwest Subsidiary, L.P.

*Columbia Medical Center of Arlington Subsidiary, L.P.

*Columbia Medical Center of Denton Subsidiary, L.P.

*Columbia Medical Center of Las Colinas, Inc.

*Columbia Medical Center of Lewisville Subsidiary, L.P.

*Columbia Medical Center of McKinney Subsidiary, L.P.

*Columbia Medical Center of Plano Subsidiary, L.P.

*Columbia North Hills Hospital Subsidiary, L.P.

Columbia North Texas Healthcare System, L.P.

Columbia North Texas Subsidiary GP, LLC

Columbia North Texas Surgery Center Subsidiary, L.P.

Columbia Northwest Medical Center, Inc.

*Columbia Ogden Medical Center, Inc.

Columbia Oklahoma Division, Inc.

Columbia Palm Beach GP, LLC

Columbia Park Healthcare System, Inc.

Columbia Park Medical Center, Inc.

*Columbia Parkersburg Healthcare System, LLC

*Columbia Plaza Medical Center of Fort Worth Subsidiary, L.P.

Columbia Psychiatric Management Co.

Columbia Resource Network, Inc.

*Columbia Rio Grande Healthcare, L.P.

*Columbia Riverside, Inc.

Columbia South Texas Division, Inc.

Columbia Specialty Hospital of Dallas Subsidiary, L.P.

Columbia Specialty Hospitals, Inc.

Columbia Surgery Group, Inc.

Columbia Tampa Bay Division, Inc.

*Columbia Valley Healthcare System, L.P.

Columbia West Bank Hospital, Inc.

*Columbia/Alleghany Regional Hospital Incorporated

Columbia/HCA Healthcare Corporation of Central Texas

Columbia/HCA Healthcare Corporation of Northern Ohio

Columbia/HCA Healthcare Corporation of South Carolina

Columbia/HCA Heartcare of Corpus Christi, Inc.

Columbia/HCA International Group, Inc.

*Columbia/HCA John Randolph, Inc.

Columbia/HCA of Baton Rouge, Inc.

Columbia/HCA of Houston, Inc.

Columbia/HCA of New Orleans, Inc.

Columbia/HCA of North Texas, Inc.

Columbia/HCA San Clemente, Inc.

Columbia-Georgia PT, Inc.

Columbia-Osceola Imaging Center, Inc.

Columbia-Quantum, Inc.

Columbia-SDH Holdings, Inc.

*Columbine Psychiatric Center, Inc.

Columbus Cath Lab, Inc.

Columbus Cath Lab, LLC

Columbus Doctors Hospital, Inc.

Concept EFL Imaging Center, LLC

Concept West EFL Imaging Center, LLC

*Conroe Hospital Corporation

Conroe Partner, LLC

Continental Division I, Inc.

CoralStone Management, Inc.

Corpus Christi Surgery Center, L.P.

Corpus Surgicare, Inc.

COSCORP, LLC

CPS TN Processor 1, Inc.

Crewe Outpatient Imaging, LLC

CRMC-M, LLC

Cumberland Medical Center, Inc.

CVMC Property, LLC

Daleville Imaging Manager, LLC

Daleville Imaging, L.P.

Davie Medical Center, LLC

Daytona Medical Center, Inc.

Deep Purple Investments, LLC

Delray EFL Imaging Center, LLC

Denver Surgicenter, LLC

Derry ASC, Inc.

Diagnostic Breast Center, Inc.

Diagnostic Mammography Services, G.P.

Doctors Hospital (Conroe), Inc.

Doctors Hospital Columbus GA-Joint Venture

Doctors Hospital of Augusta, LLC

Doctors Osteopathic Medical Center, Inc.

Doctors Same Day Surgery Center, Inc.

Doctors-I, Inc.

Doctors-II, Inc.

Doctors-III, Inc.

Doctors-IV, Inc.

Doctors-V, Inc.

Doctors-VIII, Inc.

DOMC Property, LLC

*Dublin Community Hospital, LLC

Dura Medical, Inc.

E.P. Physical Therapy Centers, Inc.

East Florida Division, Inc.

East Florida Imaging Holdings, LLC

East Pointe Hospital, Inc.

Eastern Idaho Brachytherapy Equipment Manager, LLC

Eastern Idaho Care Partners ACO, LLC

*Eastern Idaho Health Services, Inc.

Edmond Physician Hospital Organization, Inc.

*Edward White Hospital, Inc.

EHCA, LLC

El Paso Healthcare System, Ltd.

El Paso Nurses Unlimited, Inc.

*El Paso Surgicenter, Inc.

Emergency Providers Group LLC

EMMC, LLC

*Encino Hospital Corporation, Inc.

Endoscopy Surgicare of Plano, LLC

Englewood Community Hospital, Inc.

*EP Health, LLC

EP Holdco, LLC

EPIC Development, Inc.

EPIC Diagnostic Centers, Inc.

EPIC Healthcare Management Company

EPIC Properties, Inc.

EPIC Surgery Centers, Inc.

*Fairview Park GP, LLC

*Fairview Park, Limited Partnership

Fairview Partner, LLC

Far West Division, Inc.

Fawcett Memorial Hospital, Inc.

FHAL, LLC

Florida Home Health Services-Private Care, Inc.

Flower Mound Surgery Center, Ltd.

*FMH Health Services, LLC

Forest Park Surgery Pavilion, Inc.

Fort Bend Hospital, Inc.

Fort Myers Market, Inc.

Fort Walton Beach Medical Center, Inc.

Fort Worth Investments, Inc.

*Frankfort Hospital, Inc.

Frankfort Wound Care, LLC

Frisco Surgicare, LLC

Frisco Warren Parkway 91, Inc.

Ft. Pierce Surgicare, LLC

Galen (Kansas) Merger, LLC

Galen BH, Inc.

Galen Center for Professional Development, Inc.

Galen Diagnostic Multicenter, Ltd.

Galen Global Finance, Inc.

Galen GOK, LLC

Galen Health Institutes, Inc.

Galen Holdco, LLC

Galen Hospital Alaska, Inc.

Galen Hospital of Baytown, Inc.

Galen Hospital-Pembroke Pines, Inc.

Galen International Holdings, Inc.

Galen KY, LLC

Galen MCS, LLC

Galen Medical Corporation

Galen MRMC, LLC

Galen NMC, LLC

Galen NSH, LLC

Galen of Aurora, Inc.

Galen of Florida, Inc.

Galen of Illinois, Inc.

Galen of Kentucky, Inc.

Galen of Mississippi, Inc.

Galen of Virginia, Inc.

Galen of West Virginia, Inc.

*Galen Property, LLC

Galen SOM, LLC

Galen SSH, LLC

Galen Virginia Hospital Corporation

Galencare, Inc.

Galendeco, Inc.

Galen-Soch, Inc.

GalTex, LLC

Gardens EFL Imaging Center, LLC

General Hospitals of Galen, Inc.

*GenoSpace, LLC

Georgia Health Holdings, Inc.

Georgia Psychiatric Company, Inc.

Georgia, L.P.

GHC-Galen Health Care, LLC

*Good Samaritan Hospital, L.P.

Good Samaritan Hospital, LLC

Good Samaritan Surgery Center, L.P.

*GPCH-GP, Inc.

*Grand Strand Regional Medical Center, LLC

Greater Houston Preferred Provider Option, Inc.

*Green Oaks Hospital Subsidiary, L.P.

*Greenview Hospital, Inc.

Gulf Coast Division, Inc.

Gulf Coast Medical Ventures, Inc.

Gulf Coast Physician Administrators, Inc.

Gwinnett Community Hospital, Inc.

Hamilton Memorial Hospital, Inc.

HCA - Information Technology & Services, Inc.

*HCA - IT&S Field Operations, Inc.

*HCA - IT&S Inventory Management, Inc.

HCA - IT&S PBS Field Operations, Inc.

HCA - IT&S TN Field Operations, Inc.

HCA - Raleigh Community Hospital, Inc.

*HCA American Finance LLC

HCA ASD Financial Operations, LLC

HCA ASD Sales Services, LLC

*HCA Central Group, Inc.

HCA Chattanooga Market, Inc.

HCA Development Company, Inc.

*HCA Eastern Group, Inc.

HCA Endocrine Investor, LLC

HCA Health Services of California, Inc.

*HCA Health Services of Florida, Inc.

HCA Health Services of Georgia, Inc.

*HCA Health Services of Louisiana, Inc.

HCA Health Services of Miami, Inc.

HCA Health Services of Midwest, Inc.

HCA Health Services of New Hampshire, Inc.

*HCA Health Services of Tennessee, Inc.

HCA Health Services of Texas, Inc.

*HCA Health Services of Virginia, Inc.

HCA Health Services of West Virginia, Inc.

HCA Healthcare Mission Fund, LLC

HCA Healthcare, Inc.

HCA Holdco, LLC

HCA Human Resources, LLC

HCA Imaging Services of North Florida, Inc.

HCA Inc.

HCA Long Term Health Services of Miami, Inc.

*HCA Management Services, L.P.

HCA Midwest Comprehensive Care, Inc.

HCA North Texas GME PLLC

HCA Outpatient Imaging Services Group, Inc.

*HCA Pearland GP, Inc.

HCA Physician Services, Inc.

HCA Plano Imaging, Inc.

HCA Property GP, LLC

HCA Psychiatric Company

*HCA Realty, Inc.

HCA Squared, LLC

HCA Switzerland Holding GmbH

HCA Western Group, Inc.

*HCA-HealthONE LLC

HCA-Solis Holdings, Inc.

HCA-Solis Master, LLC

HCOL, Inc.

*HD&S Successor, LLC

Healdsburg General Hospital, Inc.

Health Care Indemnity, Inc.

Health Insight Capital, LLC

*Health Midwest Office Facilities Corporation

*Health Midwest Ventures Group, Inc.

Health Service Partners, Inc.

Health Services (Delaware), Inc.

Health Services Merger, Inc.

Health to You, LLC

Healthcare Sales National Management Services Group, LLC

Healthcare Technology Assessment Corporation

Healthco, LLC

Healthnet of Kentucky, LLC

HealthONE Aurora Investment, LLC

HealthONE Clear Creek, LLC

HealthONE High Street Primary Care Center, LLC

HealthOne Lincoln Investment, LLC

HealthONE Lowry, LLC

HealthONE of Denver, Inc.

HealthONE Radiation Therapy at Red Rocks, LLC

HealthONE Radiation Therapy at Thornton, LLC

HealthONE Surgicare of Ridge View, LLC

HealthONE Urologic, LLC

HealthOne Westside Investment, LLC

Healthserv Acquisition, LLC

HealthTrust Locums, Inc.

Healthtrust MOB Tennessee, LLC

Healthtrust Utah Management Services, Inc.

*HealthTrust Workforce Solutions, LLC

Healthtrust, Inc. - The Hospital Company

Healthy State, Inc.

Heart of America Surgicenter, LLC

Hearthstone Home Health, Inc.

Heathrow Imaging, LLC

*Hendersonville Hospital Corporation

Henrico Doctors Hospital - Forest Campus Property, LLC

Heritage Hospital, Inc.

HHNC, LLC

hInsight-BMA Holdings, LLC

hInsight-Customer Care Holdings, LLC

hInsight-Digital Reasoning Holdings, LLC

hInsight-Healthbox Holdings, LLC

hInsight-I2 Holdings, LLC

hInsight-InVivoLink Holdings, LLC

hInsight-Loyale Healthcare Holdings, LLC

hInsight-LS Holdings, LLC

*hInsight-Mobile Heartbeat Holdings, LLC

hInsight-NX, LLC

hInsight-OTM Holdings, LLC

hInsight-Procured Holdings, LLC

hInsight-PWS I Holdings, LLC

hInsight-VAI Holdings, LLC

HM Acquisition, LLC

Homecare North, Inc.

Hometrust Management Services, Inc.

Hospital Corp., LLC

Hospital Corporation of America

Hospital Corporation of Lake Worth

*Hospital Corporation of Tennessee

*Hospital Corporation of Utah

*Hospital Development Properties, Inc.

Hospital Partners Merger, LLC

Hospital Realty Corporation

*Houston - PPH, LLC

Houston Healthcare Holdings, Inc.

Houston Northwest Surgical Partners, Inc.

*Houston NW Manager, LLC

Houston Woman’s Hospital Partner, LLC

*HPG Enterprises, LLC

HPG Solutions, LLC

*HSS Holdco, LLC

*HSS Systems, LLC

*HSS Virginia, L.P.

HTI Gulf Coast, Inc.

HTI Health Services of North Carolina, Inc.

HTI Hospital Holdings, Inc.

*HTI Memorial Hospital Corporation

*HTI MOB, LLC

Illinois Psychiatric Hospital Company, Inc.

Imaging Services of Appomattox, LLC

Imaging Services of Jacksonville, LLC

Imaging Services of Louisiana Manager, LLC

Imaging Services of Louisiana, LLC

Imaging Services of Orlando, LLC

Imaging Services of West Boynton, LLC

IMX Holdings, LLC

Independence Surgicare, Inc.

Indian Path Hospital, Inc.

Indianapolis Hospital Partner, LLC

*Integrated Regional Lab, LLC

*Integrated Regional Laboratories, LLP

InVivoLink, Inc.

Isleworth Partners, Inc.

JDGC Management, LLC

*JFK Medical Center Limited Partnership

Johnson County Surgicenter, L.L.C.

Jupiter EFL Imaging Center, LLC

KC Surgicare, LLC

Kendall Healthcare Group, Ltd.

Kendall Regional Medical Center, LLC

Kingwood Surgery Center, LLC

*KPH-Consolidation, Inc.

L E Corporation

LAD Imaging, LLC

*Lakeview Medical Center, LLC

Lakewood Surgicare, Inc.

Laredo Medco, LLC

*Largo Medical Center, Inc.

*Las Encinas Hospital

Las Vegas ASC, LLC

*Las Vegas Surgicare, Inc.

*Lawnwood Medical Center, Inc.

Lebanon Surgicenter, LLC

*Lewis-Gale Hospital, Incorporated

*Lewis-Gale Medical Center, LLC

*Lone Peak Hospital, Inc.

*Los Robles Regional Medical Center

Loudoun Surgery Center, LLC

Louisiana Psychiatric Company, Inc.

Low Country Health Services, Inc. of the Southeast

*Management Services Holdings, Inc.

Marietta Outpatient Medical Building, Inc.

*Marietta Surgical Center, Inc.

*Marion Community Hospital, Inc.

Martin, Fletcher & Associates, L.P.

Maury County Behavioral Health, LLC

Mayhill Cancer Center, LLC

*MCA Investment Company

Meadows DME, LLC

Med Corp., Inc.

Med-Center Hosp./Houston, Inc.

Medi Flight of Oklahoma, LLC

Medical Arts Hospital of Texarkana, Inc.

Medical Care America, LLC

Medical Care Financial Services Corp.

Medical Care Real Estate Finance, Inc.

Medical Care Surgery Center, Inc.

Medical Center - West, Inc.

Medical Center Imaging, Inc.

Medical Center of Baton Rouge, Inc.

Medical Center of Plano Partner, LLC

Medical Center of Port St. Lucie, Inc.

Medical Center of Santa Rosa, Inc.

*Medical Centers of Oklahoma, LLC

Medical City Dallas Hospital, Inc.

Medical City Dallas Partner, LLC

Medical Corporation of America

Medical Imaging, Inc.

*Medical Office Buildings of Kansas, LLC

Medical Specialties, Inc.

*MediCredit, Inc.

MediPurchase, Inc.

MediStone Healthcare Ventures, Inc.

MediVision of Mecklenburg County, Inc.

MediVision of Tampa, Inc.

MediVision, Inc.

Med-Point of New Hampshire, Inc.

*Memorial Healthcare Group, Inc.

Metroplex Surgicenters, Inc.

MGH Medical, Inc.

*MH Angel Medical Center, LLLP

MH Asheville Specialty Hospital, LLC

*MH Blue Ridge Medical Center, LLLP

MH Eckerd Living Center, LLLP

*MH Highlands-Cashiers Medical Center, LLLP

*MH Hospital Holdings, Inc.

*MH Hospital Manager, LLC

*MH Master Holdings, LLLP

*MH Master, LLC

MH McDowell Imaging, LLLP

*MH Mission Hospital McDowell, LLLP

*MH Mission Hospital, LLLP

*MH Mission Imaging, LLLP

MH Transylvania Imaging, LLLP

*MH Transylvania Regional Hospital, LLLP

MHS Partnership Holdings JSC, Inc.

MHS Partnership Holdings SDS, Inc.

Miami Beach EFL Imaging Center, LLC

Miami Beach Healthcare Group, Ltd.

MidAmerica Division, Inc.

MidAmerica Oncology, LLC

Mid-America Surgery Center, LLC

Mid-Cities Surgi-Center, Inc.

Mid-Continent Health Services, Inc.

Midtown Diagnostics, LLC

*Midwest Division - ACH, LLC

Midwest Division - LRHC, LLC

*Midwest Division - LSH, LLC

*Midwest Division - MCI, LLC

*Midwest Division - MMC, LLC

*Midwest Division - OPRMC, LLC

*Midwest Division - RBH, LLC

*Midwest Division - RMC, LLC

*Midwest Holdings, Inc.

Millenium Health Care of Oklahoma, Inc.

Mission Bay Memorial Hospital, Inc.

Missouri Healthcare System, L.P.

MMC Sleep Lab Management, LLC

Mobile Corps., Inc.

*Mobile Heartbeat, LLC

Montgomery Cancer Center, LLC

*Montgomery Regional Hospital, Inc.

MOSC Sports Medicine, Inc.

*Mountain Division - CVH, LLC

Mountain Division, Inc.

*Mountain View Hospital, Inc.

Mountain West Surgery Center, LLC

MOVCO, Inc.

MP Management, LLC

MRT&C, Inc.

Nashville Psychiatric Company, Inc.

*Nashville Shared Services General Partnership

Nashville Surgicenter, LLC

Natchez Surgery Center, LLC

National Contact Center Management Group, LLC

*National Patient Account Services, Inc.

Navarro Memorial Hospital, Inc.

Network Management Services, Inc.

Network MS of Florida, Inc.

Nevada Surgery Center of Southern Hills, L.P.

Nevada Surgicare of Southern Hills, LLC

*New Iberia Healthcare, LLC

New Iberia Holdings, Inc.

*New Port Richey Hospital, Inc.

*New Rose Holding Company, Inc.

Norman Clayman Endocrine Institute, LLC

North Augusta Imaging Management, LLC

North Augusta Imaging Services, LLC

North Augusta Rehab Health Center, LLC

North Brandon Imaging, LLC

North Central Florida Health System, Inc.

North Charleston Diagnostic Imaging Center, LLC

North Florida Cancer Center Lake City, LLC

North Florida Cancer Center Live Oak, LLC

North Florida Cancer Center Tallahassee, LLC

North Florida Division I, Inc.

North Florida GI Center GP, Inc.

North Florida Physician Services, Inc.

North Florida Regional Investments, Inc.

*North Florida Regional Medical Center, Inc.

North Hills Cardiac Catheterization Center, L.P.

North Hills Catheterization Lab, LLC

*North Houston - TRMC, LLC

North Miami Beach Surgical Center, LLC

North Tampa Imaging, LLC

*North Texas - MCA, LLC

North Texas Division, Inc.

North Texas General, L.P.

North Texas Medical Center, Inc.

North Transfer Center, LLC

Northeast Florida Cancer Services, LLC

*Northern Utah Healthcare Corporation

Northern Utah Imaging, LLC

*Northern Virginia Community Hospital, LLC

Northern Virginia Hospital Corporation

Northlake Surgicare, Inc.

Northwest Florida Healthcare Systems, Inc.

Northwest Medical Center, Inc.

Notami (Opelousas), Inc.

Notami Hospitals of Florida, Inc.

*Notami Hospitals of Louisiana, Inc.

Notami Hospitals of Missouri, Inc.

*Notami Hospitals, LLC

Notami, LLC

Notco, LLC

NPAS Solutions, LLC

NPAS, Inc.

NTGP, LLC

NTMC Management Company

NTMC Venture, Inc.

Nuclear Diagnosis, Inc.

Ocala Health Imaging Services, LLC

Ocala Regional Outpatient Services, Inc.

Ocala Stereotactic Radiosurgery Partner, LLC

Ocala Stereotactic Radiosurgery, LLC

Occupational and Family Medicine of South Texas

ODP Holdings, LLC

ODP Manager, LLC

ODP Properties, LLC

Ogden Imaging, LLC

Ogden Tomotherapy Manager, LLC

*Okaloosa Hospital, Inc.

*Okeechobee Hospital, Inc.

Oklahoma Surgicare, Inc.

Oncology Services of Corpus Christi Manager, LLC

Oncology Services of Corpus Christi, LLC

OneSourceMed, Inc.

Orange Park Medical Center, Inc.

Orlando Outpatient Surgical Center, Inc.

Orthopaedic Sports Specialty Associates, Inc.

Osceola Regional Hospital, Inc.

*Outpatient Cardiovascular Center of Central Florida, LLC

Outpatient Services - LAD, LLC

*Outpatient Services Holdings, Inc.

*Oviedo Medical Center, LLC

Ozarks Medical Services, Inc.

Pacific Partners Management Services, Inc.

Palm Beach EFL Imaging Center, LLC

Palm Beach Healthcare System, Inc.

*Palms West Hospital Limited Partnership

Paragon of Texas Health Properties, Inc.

Paragon Physicians Hospital Organization of South Texas, Inc.

Paragon SDS, Inc.

Paragon Surgery Centers of Texas, Inc.

Paragon WSC, Inc.

*Parallon Business Solutions, LLC

*Parallon Enterprises, LLC

*Parallon Health Information Solutions, LLC

*Parallon Holdings, LLC

*Parallon Payroll Solutions, LLC

*Parallon Physician Services, LLC

*Parallon Revenue Cycle Services, Inc.

Park View Insurance Company

Parkersburg SJ Holdings, Inc.

Parkridge Medical Center, Inc.

Parkside Surgery Center, Inc.

Parkway Cardiac Center, Ltd.

Parkway Hospital, Inc.

Parkway Surgery Services, Ltd.

Parthenon Insurance Company, Limited

*Pasadena Bayshore Hospital, Inc.

*Pearland Partner, LLC

Pediatric Surgicare, Inc.

Pinellas Medical, LLC

Pioneer Medical, LLC

Plains Healthcare System, Inc.

Plano Heart Institute, L.P.

Plano Heart Management, LLC

Plano Surgery Center - GP, LLC

*Plantation General Hospital, L.P.

PMM, Inc.

POH Holdings, LLC

*Poinciana Medical Center, Inc.

Preferred Works WC, LLC

Primary Health Asset Holdings, Ltd.

*Primary Health, Inc.

*PTS Solutions, LLC

*Pulaski Community Hospital, Inc.

*Putnam Community Medical Center of North Florida, LLC

Putnam Hospital, Inc.

Putnam Radiation Oncology Manager, LLC

Radiation Oncology Center of Thornton, LLC

Radiation Oncology Manager, LLC

RCH, LLC

Red Rock at Smoke Ranch, LLC

Red Rock Holdco, LLC

*Reston Hospital Center, LLC

*Retreat Hospital, LLC

Richmond Imaging Employer Corp.

Rio Grande Healthcare MSO, Inc.

*Rio Grande Regional Hospital, Inc.

Riverside CyberKnife Manager, LLC

*Riverside Healthcare System, L.P.

Riverside Holdings, Inc.

*Riverside Hospital, Inc.

Riverside Imaging, LLC

Roanoke Imaging, LLC

Rosewood Medical Center, Inc.

Round Rock Hospital, Inc.

Royal Oaks Surgery Center, L.P.

S.A. Medical Center, Inc.

Salt Lake City Surgicare, Inc.

*Samaritan, LLC

San Antonio Division, Inc.

San Antonio Regional Hospital, Inc.

San Bernardino Imaging, LLC

San Joaquin Surgical Center, Inc.

*San Jose Healthcare System, LP

*San Jose Hospital, L.P.

*San Jose Medical Center, LLC

San Jose Pathology Outreach, LLC

*San Jose, LLC

Sarah Cannon Development Innovations, LLC

*Sarah Cannon Research Institute, LLC

*Sarasota Doctors Hospital, Inc.

*Savannah Health Services, LLC

*SCRI Holdings, LLC

SCRI Scientifics, LLC

*Sebring Health Services, LLC

Selma Medical Center Hospital, Inc.

Silicon Valley Health Holdings, LLC

*SJMC, LLC

Sky Ridge Spine Manager, LLC

South Atlantic Division, Inc.

South Florida Division Practice, Inc.

South Texas Surgicare, Inc.

South Transfer Center, LLC

South Valley Hospital, L.P.

*Southeast Georgia Health Services, LLC

*Southern Hills Medical Center, LLC

*Southpoint, LLC

Southwest Florida Health System, Inc.

Southwest Florida Regional Medical Center, Inc.

*Spalding Rehabilitation L.L.C.

*Spotsylvania Medical Center, Inc.

Spotsylvania Regional Surgery Center, LLC

*Spring Branch Medical Center, Inc.

*Spring Hill Hospital, Inc.

Springview KY, LLC

*SSHR Holdco, LLC

St. Mark’s Investments, Inc.

Stafford Imaging, LLC

Stiles Road Imaging LLC

Stones River Hospital, LLC

Suburban Medical Center at Hoffman Estates, Inc.

Sullins Surgical Center, Inc.

Summit General Partner, Inc.

Summit Research Solutions, LLC

Sun Bay Medical Office Building, Inc.

*Sun City Hospital, Inc.

Sun City Imaging, LLC

Sun Towers/Vista Hills Holding Co.

Sun-Med, LLC

Sunrise Hospital and Medical Center, LLC

*Sunrise Mountainview Hospital, Inc.

Sunrise Outpatient Services, Inc.

Surgical Center of Irving, Inc.

Surgical Facility of West Houston, L.P.

Surgicare America - Winter Park, Inc.

Surgicare Merger Company of Louisiana

Surgicare of Alpine, LLC

Surgicare of Altamonte Springs, Inc.

Surgicare of Anchorage, LLC

Surgicare of Arapahoe, LLC

Surgicare of Arlington, LLC

Surgicare of Ashburn, LLC

Surgicare of Augusta, Inc.

Surgicare of Aurora Endoscopy, LLC

Surgicare of Aventura, LLC

Surgicare of Bay Area Endoscopy, LLC

Surgicare of Bay Area, LLC

Surgicare of Bayonet Point, Inc.

Surgicare of Bayside, LLC

Surgicare of Bountiful, LLC

*Surgicare of Brandon, Inc.

Surgicare of Brentwood, LLC

Surgicare of Brooksville, LLC

Surgicare of Brownsville, LLC

Surgicare of Central Florida, Inc.

Surgicare of Central San Antonio, Inc.

Surgicare of Chattanooga, LLC

Surgicare of Chippenham, LLC

Surgicare of Citrus, LLC

Surgicare of Clarksville, LLC

Surgicare of Corpus Christi, LLC

Surgicare of Countryside, Inc.

Surgicare of Dallas Specialty, LLC

Surgicare of Denton, Inc.

Surgicare of Denver Mid-Town, Inc.

Surgicare of Denver, LLC

Surgicare of Evans, Inc.

Surgicare of Fairfax, Inc.

*Surgicare of Florida, Inc.

Surgicare of Flower Mound, Inc.

Surgicare of Focus Hand, LLC

Surgicare of Fort Worth Co-GP, LLC

Surgicare of Fort Worth, Inc.

Surgicare of Ft. Pierce, Inc.

Surgicare of Good Samaritan, LLC

Surgicare of Gramercy, Inc.

Surgicare of Greenview, Inc.

Surgicare of Hanover, Inc.

*Surgicare of Houston Women’s, Inc.

Surgicare of Houston, LLC

Surgicare of Indianapolis, Inc.

Surgicare of Kansas City, LLC

Surgicare of Kingwood, LLC

Surgicare of Kissimmee, Inc.

Surgicare of Lakeview, Inc.

Surgicare of Las Vegas, Inc.

Surgicare of Laurel Grove, LLC

Surgicare of Lorain County, Inc.

Surgicare of Los Gatos, Inc.

Surgicare of Los Robles, LLC

Surgicare of Madison, Inc.

*Surgicare of Manatee, Inc.

Surgicare of McKinney, Inc.

Surgicare of Medical City Dallas, LLC

Surgicare of Memorial Endoscopy, LLC

Surgicare of Merritt Island, Inc.

Surgicare of Miami Lakes, LLC

Surgicare of Mountain West, LLC

Surgicare of Mt. Ogden, LLC

Surgicare of Nashville, LLC

Surgicare of Natchez, LLC

*Surgicare of Newport Richey, Inc.

Surgicare of North San Antonio, Inc.

Surgicare of Northeast San Antonio, Inc.

Surgicare of Orange Park, Inc.

Surgicare of Orlando, Inc.

Surgicare of Overland Park, LLC

*Surgicare of Palms West, LLC

Surgicare of Park Ridge, LLC

Surgicare of Pasadena, Inc.

Surgicare of Pavilion, LLC

Surgicare of Physicians West El Paso, LLC

Surgicare of Pinellas, Inc.

Surgicare of Plano, Inc.

Surgicare of Plantation, Inc.

Surgicare of Port Charlotte, LLC

Surgicare of Port St. Lucie, Inc.

Surgicare of Portsmouth, LLC

Surgicare of Premier Orthopaedic, LLC

Surgicare of Reston, Inc.

Surgicare of Ridgeline, LLC

Surgicare of Riverwalk, LLC

Surgicare of Roanoke, LLC

Surgicare of Rose, LLC

Surgicare of Round Rock, Inc.

Surgicare of Royal Oaks, LLC

Surgicare of Salem, LLC

Surgicare of Silicon Valley, LLC

Surgicare of Sky Ridge, LLC

Surgicare of South Austin, Inc.

Surgicare of Southeast Denver, Inc.

Surgicare of Southern Kentucky, LLC

Surgicare of Spotsylvania, LLC

Surgicare of St. Andrews, Inc.

Surgicare of StoneSprings, LLC

Surgicare of Stuart, Inc.

Surgicare of Sugar Land, Inc.

Surgicare of Swedish, LLC

Surgicare of Tallahassee, Inc.

Surgicare of Terre Haute, LLC

Surgicare of Thornton, LLC

Surgicare of Travis Center, Inc.

Surgicare of Tulsa, Inc.

Surgicare of Utah, LLC

Surgicare of Wasatch Front, LLC

Surgicare of West Hills, Inc.

Surgicare of Westlake, Inc.

Surgicare of Wichita, Inc.

Surgicare of Willis, LLC

Surgicare of Wilson County, LLC

Surgicare of Winchester, LLC

Surgicare Outpatient Center of Baton Rouge, Inc.

Surgicare Outpatient Center of Jackson, Inc.

Surgicenter of East Jefferson, Inc.

Surgico, LLC

SWMC, Inc.

Tallahassee Community Network, Inc.

*Tallahassee Medical Center, Inc.

Tampa Bay Health System, Inc.

Tampa Surgi-Centre, Inc.

TBHI Outpatient Services, LLC

*TCMC Madison-Portland, Inc.

Teays Valley Health Services, LLC

Tennessee Valley Outpatient Diagnostic Center, LLC

*Terre Haute Hospital GP, Inc.

*Terre Haute Hospital Holdings, Inc.

*Terre Haute MOB, L.P.

*Terre Haute Regional Hospital, L.P.

Texas HSS, LLC

Texas Psychiatric Company, Inc.

*The Regional Health System of Acadiana, LLC

The West Texas Division of Columbia, Inc.

*Timpanogos Regional Medical Services, Inc.

Total Imaging - Hudson, LLC

Total Imaging - North St. Petersburg, LLC

Total Imaging - Parsons, LLC

Tri Cities Health Services Corp.

Tri-County Community Hospital, Inc.

*Trident Medical Center, LLC

TriStar Health System, Inc.

Ultra Imaging Management Services, LLC

Ultra Imaging of Tampa, LLC

University Hospital, Ltd.

Utah Imaging GP, LLC

*Utah Medco, LLC

Valify, Inc.

Value Health Holdings, Inc.

Value Health Management, Inc.

Venture Medical Management, LLC

*VH Holdco, Inc.

*VH Holdings, Inc.

Vidalia Health Services, LLC

Village Oaks Medical Center, Inc.

VIP, Inc.

Virginia Care Partners ACO LLC

Virginia Hematology & Oncology Associates, Inc.

*Virginia Psychiatric Company, Inc.

Virginia Quality Care Partners, LLC

*Vision Consulting Group LLC

*Vision Holdings, LLC

W & C Hospital, Inc.

*Walterboro Community Hospital, Inc.

Warren County Ambulance Service, LLC

*WCP Properties, LLC

*Weatherford Health Services, LLC

Wesley Cath Lab, LLC

Wesley Manager, LLC

*Wesley Medical Center, LLC

West Boynton Beach Open Imaging Center, LLC

West Creek Ambulatory Surgery Center, LLC

West Creek Medical Center, Inc.

*West Florida - MHT, LLC

*West Florida - PPH, LLC

West Florida Division, Inc.

West Florida HealthWorks, LLC

West Florida Imaging Services, LLC

West Florida PET Services, LLC

West Florida Professional Billing, LLC

*West Florida Regional Medical Center, Inc.

West Hills Hospital

West Houston ASC, Inc.

West Houston Outpatient Medical Facility, Inc.

West Houston Surgicare, Inc.

West Houston, LLC

West Jacksonville Medical Center, Inc.

West Jordan Hospital Corporation

West Los Angeles Physicians’ Hospital, Inc.

West McKinney Imaging Services, LLC

West Paces Services, Inc.

West Valley Imaging, LLC

*West Valley Medical Center, Inc.

Westbury Hospital, Inc.

Westminster Community Hospital

WHG Medical, LLC

*WHMC, Inc.

Wildwood Medical Center, Inc.

Wilson County Outpatient Surgery Center, L.P.

WJHC, LLC

Woman’s Hospital Merger, LLC

*Woman’s Hospital of Texas, Incorporated

Women’s & Children’s Pediatric Hematology/Oncology Center, LLC

Women’s & Children’s Pulmonology Clinic, LLC

Women’s Hospital Indianapolis GP, Inc.

Women’s Hospital Indianapolis, L.P.

The affiliates of HCA Healthcare, Inc. listed below have entered into term promissory notes with Western Plains Capital, Inc., a subsidiary guarantor. The notes are owed to Western Plains Capital, Inc. and pledged as collateral for the secured notes.

Ambulatory Surgery Center Group, Ltd.

Arapahoe Surgicenter, LLC

Atlanta Surgery Center, Ltd.

Bay Area Surgicenter, LLC

Bayonet Point Surgery Center, Ltd.

Bayside Ambulatory Center, LLC

Belleair Surgery Center, Ltd.

Brentwood Surgery Center, LLC

Brownsville Surgicenter, LLC

Calloway Creek Surgery Center, L.P.

Carolina Regional Surgery Center, Ltd.

Centennial Surgery Center, L.P.

Central Utah Surgicenter, LLC

Centrum Surgery Center, Ltd.

Chippenham Ambulatory Surgery Center, LLC

Clarksville Surgicenter, LLC

Clear Lake Surgicare, Ltd.

Columbia Surgicare of Augusta, Ltd.

Comprehensive Digestive Surgicenter, LLC

Coral Springs Surgi-Center, Ltd.

Countryside Surgery Center, Ltd.

Denton Regional Ambulatory Surgery Center, L.P.

Denver Surgicenter, LLC

Doctors Hospital Surgery Center, L.P.

Doctors Same Day Surgery Center, Ltd.

El Paso Surgery Centers, L.P.

Fairfax Surgical Center, L.P.

Florida Outpatient Surgery Center, Ltd.

Gramercy Surgery Center, Ltd.

HealthONE Ridge View Endoscopy Center, LLC

Jacksonville Surgery Center, Ltd.

Johnson County Surgery Center, L.P.

KC Pain ASC, LLC

Kingwood Surgery Center, LLC

Las Colinas Surgery Center, Ltd.

Las Vegas Surgicare, Ltd.

Lincoln Surgery Center, LLC

Los Robles Surgicenter, LLC

Manatee Surgicare, Ltd.

Marietta Outpatient Surgery, Ltd.

MEC Endoscopy, LLC

Med City Dallas Outpatient Surgery Center, L.P.

Medical City Surgery Center of Alliance, LLC

Medical City Surgery Center of Frisco, LLC

Medical Plaza Ambulatory Surgery Center Associates, L.P.

Mt. Ogden Utah Surgical Center, LLC

New Port Richey Surgery Center, Ltd.

North Florida Radiation Oncology, LLC

North Florida Regional Freestanding Surgery Center, L.P.

North Hills Surgicare, L.P.

North Miami Beach Surgery Center Limited Partnership

North Palm Beach County Surgery Center, LLC

North Suburban Spine Center, L.P.

Northlake Surgical Center, L.P.

ODP Manager, LLC

Oklahoma Outpatient Surgery Center Limited Partnership

Orlando Surgicare, Ltd.

Outpatient Surgical Services, Ltd.

Outpatient Women’s and Children’s Surgery Center, Ltd.

Palms West Surgery Center, Ltd.

Park Central Surgical Center, Ltd.

Park Ridge Surgery Center, LLC

Physicians Ambulatory Surgery Center, LLC

Physicians West Surgicenter, LLC

Plano Ambulatory Surgery Associates, L.P.

Port St. Lucie Surgery Center, Ltd.

Premier ASC, LLC

Putnam Radiation Oncology, LLC

Red Rocks Surgery Center, LLC

Reston Surgery Center, L.P.

Riverwalk ASC, LLC

Roanoke Surgery Center, L.P.

Rocky Mountain Surgery Center, LLC

Rose Ambulatory Surgery Center, L.P.

Sky Ridge Surgery Center, L.P.

Southern Kentucky Surgicenter, LLC

Specialty Surgicare of Las Vegas, LP

St. Mark’s Ambulatory Surgery Associates, L.P.

Sugar Land Surgery Center, Ltd.

Summit Surgery Center, L.P.

Surgery Center of Atlantis, LLC

Surgery Center of Aventura, Ltd.

Surgery Center of Independence, L.P.

Surgery Center of Overland Park, L.P.

Surgery Center of Port Charlotte, Ltd.

Surgery Center of the Rockies, LLC

Surgical Park Center, Ltd.

Surgicare of St. Andrews, Ltd.

Surgicare of Wichita, LLC

Surgicenter of Kansas City, LLC

Tallahassee Orthopaedic Surgery Partners, Ltd.

Tarrant County Surgery Center, L.P.

University Healthcare System, L.C.

Urology Surgery Center of Colorado, LLC

Utah Surgery Center, L.P.

West Hills Surgical Center, Ltd.

West Park Surgery Center, L.P.

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Samuel N. Hazen, certify that:

I have reviewed this quarterly report on Form 10-Q of HCA Healthcare, Inc.;
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/S/ SAMUEL N. HAZEN
	Samuel N. Hazen
	Chief Executive Officer

Date: May 3, 2022

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, William B. Rutherford, certify that:

I have reviewed this quarterly report on Form 10-Q of HCA Healthcare, Inc.;
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/S/ WILLIAM B. RUTHERFORD
	William B. Rutherford
	Executive Vice President and Chief Financial Officer

Date: May 3, 2022

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HCA Healthcare, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/S/ SAMUEL N. HAZEN
	Samuel N. Hazen
	Chief Executive Officer

May 3, 2022

By:	/S/ WILLIAM B. RUTHERFORD
	William B. Rutherford
	Executive Vice President and Chief Financial Officer

May 3, 2022